Skip to main content Accessibility help
×
Home
  • Print publication year: 2016
  • Online publication date: June 2017

Chapter 20 - Developmental and Syndromic Disturbances of the Craniofacial Region

Related content

Powered by UNSILO
1.Baldwin, DJ, Thayalan, K, Amrita, J, et al. Glial choristoma of the tongue: report of a case and clinicopathological features. Int J of Pediatr Dent, 2009, 19: 219221.
2.Martinez-Peῆuela, A, Quer, S, Beloqui, R. Glial choristoma of the middle ear: report of 2 cases. Otology and Neurology, 2011, 32: e26e27.
3.Strome, SE, McClatchey, K, Kileny, PR, et al. Neonatal choristoma of the tongue containing glial tissue. Diagnostic and surgical considerations. Int J Pediatr Otorhino Laryngol, 1995, 33: 265273.
4.Sun, LS, Zhi-Peng, S, Xu-Chen, MA. Glial choristoma in the oral and maxillofacial region. A clinicopathologic study of 6 cases. Arch Pathol Lab Med, 2008, 132: 984998.
5.Fan, SQ, Ou, YM, Liang, QC. Glial choristoma of the tongue: report of a case and review of the literature. Pediatr Surg Int, 2008, 24: 515519.
6.Takamizawa, S, Inoue, T, Ono, Y, et al. A case report of glial choristoma of the tongue. J Pediatr Surg, 2006, 41: e13e15.
7.Fordyce, JA. A peculiar affection of the mucous membrane of the lips and oral cavity. J Cutan Dis, 1896, 14: 413419.
8.Lee, JH, Lee, JH, NA HK: Clinicopathologic manifestations of patients with Fordyce’s spots. Ann Dermatol, 2012, 24: 103106.
9.Oliver, JH. Fordyce granules on the prolabia and oral mucous membranes of a selected population. SADJ, 2006, 61: 7274.
10.DeFelice, C, Patrini, S, Chitano, G. et al. Fordyce granules and hereditary non-polyposis colorectal cancer syndrome. Gut, 2005, 41: 12791282.
11.Miller, AS, McCrea, MW. Sebaceous gland adenoma of the buccal mucosa. J Oral Surg, 1968, 26: 593595.
12.Miller, ML, Harford, RR, Yeager, JK. Fox Fordyce disease treated with topical clindamycin solution. Arch Dermatol, 1995, 131: 11121113.
13.Siggers, DC. Cleidocranial dysostosis. Dev Med Child Neurol, 1975, 4: 522524.
14.Shen, Z, Chio, C, Chun, Z, et al. Cleidocranial dysplasia: Report of 3 cases and literature review. Clinical Pediatrics, 2009, 2: 194198.
15.Bufalino, A, Paranaiba, LMR, Gouvêa, AF, et al. Cleidocranial dysplasia: oral features and genetic analysis of 11 patients. Oral Diseases, 2012, 18: 184190.
16.Ducy, P, Zhang, R, Geoffroy, V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997, 89: 747754.
17.Komori, T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res, 2010, 339: 189195.
18.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 231232.
19.Suda, N, Hattori, M, Kosaki, K, et al. Correlation between genotype and supernumerary tooth formation in cleidocranial dysplasia. Orthod Craniofac Res, 2010, 13: 197202.
20.Gorlin, RJ, Cohen, MN, Levin, LS. Syndromes of the Head and Neck. Ed 3, New York NY, Oxford University Press; 1990: 249253.
21.Jarvis, JL, Keats, TE. Cleidocranial dysostosis: a review of 40 new cases. Am J Roentgenol Radium Ther Nucl Med, 1974, 121: 516.
22.Perdigao, PF, Silva, ED, Sakurai, E, et al. Idiopathic bone cavity: a clinical, radiographic and histological study. Brit J Oral MG, 2003, 41: 407409.
23.Shigematsu, K, Fujita, W. Atypical simple bone cyst of the mandible. J Oral Maxillofac Surg, 1994, 23: 298299.
24.Manor, E, Kachko, L, Puterman, MB. Cystic lesions of the jaws: a clinicopathological study of 322 cases and review of the literature. Int J Med Sci, 2012, 9: 2026.
25.Patrikiou, A, Sepheriadouo-Mauropulou, G, Zambelis, G. Bilateral traumatic bone cysts of the mandible. Oral Surg, 1981, 51: 131133.
26.Zhu, L, Wang, X. Histological examination of the auricular cartilage and pseudocyst of the auricle. J Laryngol Otol, 1999, 106: 103104.
27.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 216217.
28.Velez, I, Siegel, MA, Mintz, SM et al. The relationship between idiopathic bone cavity and orthodontic tooth movement: analysis of 44 cases. Dentomaxillofac Radiol, 2010, 39: 162166.
29.Cortell-Ballester, I, Figueiredo, R, Berini-Aytes, L, et al. Traumatic bone cyst: a retrospective study of 21 cases. Med Oral Pathol Oral Cir Bucal 2009, 14: E239E243.
30.Kaffe, I, Littner, MM, Arensburg, B. The anterior buccal mandibular depression. Physical and radiologic features. Oral Surg Oral Med Oral Pathol, 1990, 69: 647654.
31.Apruzzese, D, Longoni, S. Stafne cyst in an anterior location. Oral Maxillofac Surg, 1999, 57: 333338.
32.Stafne, EC. Bone cavities situated near the angle of the mandible. J Am Dent Assoc, 1942, 29: 19691972.
33.Buchner, A, Carpenter, WM, Merrell, PW, et al. Anterior lingual salivary gland defect. Evaluation of twenty-four cases. Oral Surg Oral Med Oral Pathol, 1991, 71: 131136.
34.Shimizu, M, Osa, N, Okamura, K, et al. CT analysis of the Stafne’s bone defects of the mandible. Dentomaxillofac Radiol, 2006, 35: 95102.
35.Baughman, R. Testing your diagnostic skills. Case No. 2. Lingual mandibular salivary gland depression. Todays FDA, 2006, 18: 2023.
36.Sisman, Y, Miloglu, O, Sekerci, AE, et al. Radiographic evaluation of the prevalence of Stafne bone defect: a study from two centres in Turkey. Dentomaxillofacial Radiol, 2011, 35: 17.
37.Reye, RDK. A consideration of certain subdermal fibromatous tumors of infancy. J Pathol, 1956, 72: 149154.
38.Sotelo-Avilla, C, Bale, PM. Subdermal fibrous hamartomas of infancy: pathology of 40 cases and differential diagnosis. Pediatr Path, 1994, 14: 3952.
39.Paller, AS, Gonzalez-Grussi, F, Sherman, JO. Fibrous hamartomas of infancy: eight additional cases and a review of the literature. Arch Dermatol, 1989, 125: 8891.
40.Scott, DM, Pena, JR, Omura, E. Fibrous hamartomas of infancy. J Am Acad Dermatol, 1999, 41: 857858.
41.Westphal, SL, Bancila, E, Milgraum, SS. Fibrous hamartomas of infancy presenting as an inflamed epidermoid cyst. Pediatr Dermatol, 1990, 7: 157.
42.Boquot, JE, Gundlach, KKH. Odd tongues: the prevalence of common tongue lesions in 23,616 white Americans over 35 years of age. Quintessence Int, 1986, 17: 719730.
43.Ugar-Cankel, D, Denizci, S, Hocaoglu, J. Prevalence of tongue lesions among Turkish school children, Sandi Med, 2005, 26: 19621967.
44.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 99.
45.Mathew, AL, Pai, KM, Sholapurkar, AA, et al. The prevalence of oral mucosal lesions in patients visiting a dental school in Southern India. Indian J Dent Res, 2008, 19: 99103.
46.Koay, CL, Lim, JA, Siar, CH. The prevalence of tongue lesions in Malaysian dental out-patients from the Klang valley area. Oral Dis, 2011, 17: 210216.
47.Ohtani, J, Hoffman, WY, Vargevik, K. Team management and treatment outcomes for patients with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedies, 2012, 141: 574581.
48.Poswillo, D. The pathogenesis of first and second bronchial arch syndrome. Oral Surg, Oral Med, Oral Pathol, 1973, 35: 301328.
49.Kelberman, D, Tyson, DC, Chandler, AM, et al. Hemifacial microsomia: progress to understanding the genetic basis of a complex malformation syndrome. Hum Genet 2001, 109: 638645.
50.Pruzansky, S. Not all dwarfed mandibles are alike. Birth Defects, 1969, 4: 120129.
51.Cousley, RR A comparison of two classification systems for hemifacial microsomia. Br J Oral Maxillof Surg, 1993, 31: 7882.
52.Zanardi, G, Parente, EV, Esteves, LS. Orthodontic and surgical treatment of a patient with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedics, 2012, 141: 51305139.
53.Miranda, R, Barros, LM, Nogueira dos Santos, LA, et al. Clinical and imaging features in a patient with hemifacial hyperplasia. J Oral Sci, 2010, 52: 509512.
54.Bergman, JA. Primary hemifacial hypertrophy. Review and report of a case. Arch Otolaryngol, 1973, 97: 490494.
55.Yashimoto, H, Hano, H, Kobayashi, K, et al. Increased proliferative activity of osteoblasts in congenital hemifacial hypertrophy. Plast Reconstr Surg, 1998, 102: 16051610.
56.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Quintessence Publishing Company, 2012, 240
57.Islam, MN, Bhattacharyya, I, Ojha, J, et al. Comparison between true and partial hemifacial hypertrophy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 104: 501509.
58.Azevedo, RA, Veronica, FS, Sarmento, VA, et al. Hemifacial hyperplasia. A case report. Quintessence Int, 2005, 36: 483486.
59.Wisniewski, SA, Trzeciak, WH. A new mutation resulting in the truncation of the TRAF6-interacting domain of XEDAR: a possible novel cause of hypohidrotic ectodermal dysplasia. J Med Genet, 2012, 49: 499501.
60.Clarke, A. Hypohidrotic ectodermal dysplasia. J Med Genet, 1987, 24: 659663.
61.Subramaniam, P, Neeraja, G. Witkop’s tooth and nail syndrome: a multifaceted approach to dental management. J Indian Soc Pedod Prev Dent, 2008, 26: 2225.
62.Lamartine, J. Towards a new classification of ectodermal dysplasias. Cin Exp Dermatol, 2003, 28: 351355.
63.Priolo, M, Lagana, C. Ectodermal dysplasia a new clinical-genetic classification. J Med Genet, 2001, 38: 579585.
64.Guckes, AD, Brahim, JS, McCarthy, GR, et al. Using endosseous dental implants for patients with ectodermal dysplasia. JADA, 1991, 122: 5962.
65.Ekstrand, K, Thomsson, M. Ectodermal dysplasia with partial anodontia: prosthetic treatment with implant prosthesis. J Dent Child, 1988, 4: 282284.
66.Smith, RA, Vargervik, K, Kearns, G, et al. Placement of an endosseous implant in a growing child with ectodermal dysplasia. Oral Surg Oral Med Oral Pathol, 1993, 75: 669673.
67.Urzua, B, Ortega-Pento, , Morales-Bozo, et al. Defining a new candidate gene for amelogenesis imperfecta: from molecular genetics to biochemistry. Biochem Genet, 2011, 49: 104121.
68.Stephanopoulos, G, Garefalaki, E, Lyroudia, K. Genes and related proteins involved in amelogenesis imperfect. J Dent Res, 2005, 84: 11171126.
69.Weinmann, JP, Svobcda, JF, Woods, RW. Hereditary disturbances of enamel formation and calcification. J Am Dent Assoc, 1945, 32: 397418.
70.Chaudhary, M, Dixit, S, Singh, A. Amelogenesis imperfecta: reporting of a case and review of the literature. J Oral Maxillofac Pathol, 2009, 13: 7077.
71.Witkop, CJ Jr. Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification. J Oral Pathol Med, 1989, 17: 547543.
72.Schulze, C. Erbbedingte strukturanomalicin menschlicher zahne. Acta Genet Med Gemellol, 1957, 7: 231235.
73.Kinney, H, Pople, JA, Driessen, CH, et al. Intrafibrillar mineral may be absent in dentinogenesis imperfecta type II. J Dental Res, 2001, 1:80: 15551559.
74.Thofakura, SR, Mah, J, Srinivasan, R, et al. The non collagenous dentin matrix proteins are involved in dentinogenesis imperfecta type II. J Dent Res 2000, 79: 835839.
75.Bhandari, S, Pannu, K. Dentinogenesis imperfecta: a review and case report of a family over four generations. Indian J Dent Res, 2008, 19: 357361.
76.Shields, ED, Bixler, D, El-Kafrawy, AM. A proposed classification of heritable human dentin defect with a description of a new entity. Arch Oral Biol, 1973, 18: 543553.
77.Levin, LS, Leaf, SH, Jemini, RJ, et al. Dentinogenesis imperfecta in the Brandywine isolate hereditary opalescent dentin in an Ashkenazic Jewish family. Oral Surg Oral Med Oral Pathol, 1985, 59: 608615.
78.Von Marschall, Z, Mok, S, Phillips, MD. Rough endoplasmic reticulum trafficking errors by different classes of mutant dentin sialophosphorprotein (DSPP) causes dominant negative effects in both dentinogenesis imperfecta and dentin dysplasia by encapping normal DSPP. J Bone Miner Res, 2012, 27: 13091321.
79.Buday, K. Beiträge zar Lehre der osteogenesis imperfect, 1895.
80.Sillence, DO, Senn, A, Danks, DM. Genetic heterogenicity in osteogenesis imperfecta. J Med Genet, 1979, 16: 101116.
81.Rosen, A, Modig, M, Larson, O. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. Int J Oral Surg, 2011, 40: 866873.
82.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 232236.
83.Huber, MA. Osteogenesis imperfect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103: 314320.
84.Bergstrom, L. Osteogenesis imperfecta: otologic and maxillofacial aspects. Laryngoscope, 1977, 87: 142.
85.O’Connel, AC, Marini, JC. Evaluation of oral problems in an osteogenesis imperfect population. Oral SLurg Oral Med Oral Pathol Oral Radiol Endod, 1999, 87: 189196.
86.Kindelan, J, Tobin, M, Robert-Harry, RA. Orthodontic and orthognatic management of a patient with osteogenesis imperfect and dentinogenesis imperfect. A case report. J Orthod 2003, 30: 291296.
87.Marszalek, B, Wyojcicki, P, Kobus, K, et al. Clinical features, treatment and genetic background of Treacher Collins syndrome. J Appl Genet, 2002, 43: 223233.
88.Dixon, J, Edwards, SJ, Anderson, L. Identification of the complete coding sequence and genetic organization of the Treacher Collins syndrome gene. Genome Res, 1997, 7: 223234.
89.Rovin, S, Dachi, SF, Borenstein, DB, et al. Mandibulofacial dysostosis, a familial study of five generations. J Pediat, 1964, 65: 215221.
90.Jones, KL, Smith, DW, Harvey, MA, et al. Mandibulofacial dysostosis older paternal age and fresh gene mutation: data on additional disorders. J Pediat, 1975, 86: 8488.
91.LeMerrer, M, Cikuli, M, Ribier, J, et al. Acrofacial dysostosis. Am J Med Genet, 1989, 33: 318322.
92.Dixon, J, Trainor, MJ, Dixon, MJ. Treacher Collins syndrome. Orthodontics and Craniofacial Research, 2007, 10: 8895.
93.Horiuchi, K, Ariga, T, Fujioka, H, et al. Mutational analysis of the TCOF1 gene in 11 Japanese patients with Treacher Collins syndrome and mechanism of mutagenesis. J Med Genet, 2005, 134:363: 367.
94.Cohen, J, Ghezzi, F, Goncalves, L, et al. Prenatal sonographic diagnosis of Treacher Collins Syndrome: A case and review of the literature. Am J Perinatol, 1995, 12: 416419.
95.Cannon, AB. White nevus of the mucosa (naevus spongiosus albus mucosa) Arch Derm Syphiol, 1935, 31: 365373.
96.Hernandez-Martin, A, Fernandez-Lopez, E, deUnamuno, M. Diffuse whitening of the oral mucosa in a child. Pediatr Dermatol 1997, 14: 316320.
97.Naseem, S, Brady, R, McDonald, J. Diffuse white oral plaques. Clinical Infectious Diseases 2003, 36: 519520.
98.Jorgenson, RJ, Levin, LS. White sponge nevus. Arch Dermatol 1981, 117: 7376.
99.Allingham, RR, Seo, B, Rapersaud, E, et al. A duplication in chromosome 4q35 is associated with hereditary benign intraepithelial dyskeratosis. Am J Hum Genet 2001, 68: 491494.
100.Chao, SC, Tsai, Y-M, Yang, MH, et al. A novel mutation in the keratin 4 gene causing white sponge naevus. Br J Dermatol 2003, 184: 11251128.
101.Sadeghi, EM, Witkop, CJ. The presence of Candida albicans in hereditary benign intraepithelial dyskeratosis. An ultrastructural observation. Oral Surg Oral Med Oral Pathol 1979, 48: 342346.
102.Greer, RO Jr. Oral manifestations of smokeless tobacco use. Otolaryngologic Clinics of North America, 2010, 44: 3156.
103.Lim, J, Ng, S. Oral tetracycline rinse improves symptoms of white sponge nevus. J Am Acad Dermatol, 1992, 26: 10031005.
104.Elliott, M, Bayly, R, Cole, T, Temple, IK, Maher, ER. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clinical Genetics, 1994, 46, 168174.
105.Thorburn, MJ, Wright, ES, Miller, CG, Smith-Read, EHL. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. American J Diseases of Children, 1970, 119: 316321.
106.Pettenati, MJ, Haines, JL, Higgins, RR, Wappner, RS, Palmer, CG, Weaver, DD. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Human Genetics, 1986, 74: 143154.
107.DeBaun, MR, Niemitz, EL, McNeil, DE, Brandenburg, SA, Lee, MP, Feinberg, AP. Epigenetic alterations of H19 and L1T1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Human Genetics, 2002, 70: 604611.
108.Ullbro, C, Crossner, CG, Nederfors, T, Alfadley, A, Thestrup-Pedersen, K. Dermatological and oral findings in a cohort of 47 patients with Papillon-Lefevre syndrome. J Am Acad Dermatol, 2003, 48: 345351.
109.Cagli, NA, Hakki, SS, Darsun, R, et al. Clinical genetic, and biochemical findings in two siblings with Papillon-Lefévre syndrome. J Periodontal, 2005, 76: 23222329.
110.Wani, A, Devkar, N, Patole, M, Shouche, Y. Description of two new cathespin C gene mutations in patients with Papillon-Lefévre syndrome. J Peridontol, 2005, 76: 23222329.
111.Zadik, Y, Drucker, S, Pallmon, S. Migratory stomatitis (ectopic geographic tongue) on the floor of the mouth. J Am Acad Dermatol, 2011, 6: 459460.
112.Kvien, T, Glennas, A, Melby, K, Granfors, K, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatology, 1994, 21: 115122.
113.Hill Gaston, JS, Lillicrap, MS. Arthritis associated with enteric infection. Clinical Rheumatology, 2003, 17: 219239.
114.Suhanga, J, Chakshu, A, Mohideen, K, et al. Cherubism combined with epilepsy, mental retardation and gingival fibromatosis. (Ramon syndrome): a case report. Head and Neck Pathol, 2010, 4: 12131.
115.Ramon, Y, Berman, W, Bubus, JJ. Gingival fibromatosis combined with Cherubism. Oral Surg, Oral Med, Oral Pathol, 1967, 24: 436448.
116.Hall, G. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol, 2001, 112: 851862.
117.Kasabach, HH, Merritt, KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child, 1940, 59: 1063.
118.el-Dessouky, M, Azmy, A, Raine, P, Young, D. Kasabach-Merritt syndrome. J Pediatr Surg, 1998, 23: 109111.
119.Enjolras, O, Mulliken, J, Wassef, M, Frieden, I, Rieu, P, Burrows, P, Salhi, A, Léauté-Labrèze, C, Kozakewich, H. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol, 2000, 42: 224235.
120.Stone, J. Neurological rarity: Parry-Romberg syndrome. Practical Neurology, 2006, 6: 185188.
121.Leao, M, da Silva, ML. Progressive hemifacial atrophy with agenesis of the head and the caudate nucleus. J Med Genetics, 1994, 31: 969971.
122.Muchnik, RS, Aston, SJ, Rees, TD. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmology, 1979, 88: 889897.
123.Lewkonia, RM, Lowry, RB, Opitz, JM. Progressive hemifacial atrophy (Parry-Romberg syndrome): report with review of genetics and nosology. Am J Med Genetics, 1983, 14: 385390.
124.Inigo, F, Jimenez-Murat, Y, Arroyo, O, Fernandez, M, Ysunza, A. Restoration of facial contour in Romberg’s disease and hemifacial microsomia. Experience with 118 cases. Microsurgery, 2000, 20: 167172.
125.Shirley, MD, Tang, H, Gallione, CJ, et al. Sturge-Weber syndrome and Port-wine stains caused by somatic mutations in GNAQ. New England J Med, 2013, 368: 19711979.
126.Sturge, WA. A case of partial epilepsy, apparently due to a lesion of one of the vasomotor centres of the brain. Transactions of the Clinical Society of London, 1879, 12: 162.
127.Greenwood, M, Meechan, JG. General medicine and surgery for dental practitioners Part 4: Neurological disorders. Br Dent, 2003, 195: 1925.
128.Weber, FP. Right-sided hemi-hypertrophy resulting from right-sided congenital spastic hemiplegia, with a morbid condition of the left side of the brain, revealed by radiograms. J Neurology and Psychopathology (London), 1922, 3: 134139.
129.Kubota, M, Usami, I, Yamakawa, M, Tomita, Y, Haruta, T. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. J Paediatrics and Child Health, 2008, 44: 359362.
130.Scardina, GA, Fucà, G, Carini, F, et al. Oral necrotizing microvasculitis in a patient affected by Kawasaki disease. Medicina Oral, Patologia Oral Y Cirugia Buc, 2007, 12: E560E564.
131.Do, JH, Baek, JG, Kim, HJ, et al. Kawasaki disease presenting as parotitis in a 3 month old infant. Korean Circulation Journal, 2009, 39: 502504.
132.Michie, C, Kinsler, V, Tulloh, R, Davidson, S. Recurrent skin peeling following Kawasaki disease. Archives of Disease in Childhood, 2000, 83: 353355.
133.Gardner, EJ, Richards, RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet, 1953, 5: 139147.
134.Knudsen, AL, Bisguard, ML, Bűlow, S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer, 2003, 2: 4355.
135.Miyoshi, Y, Nagase, H, Ando, H, et al. Somatic mutations of the APC gene in colorectal tumors. Mutation in the cluster region in the APC gene. Hum Mol Genet, 1992, 1: 229233.
136.Saurin, JC, Chayvialle, JA, Ponchon, T. Management of duodenal adenomas in familial adenomatous polyposis. Fam Cancer, 2008, 7: 173177.
137.Lourenco, SV, Boggio, P, Suquyama, K, et al. Severe and relapsing upper lip enlargement in a 10 year old boy. Acta Paediatr, 2010, 99: 1958.
138.Rogers RS, . Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin, 1996, 14: 371379.
139.Khouri, JM, Bohane, TD, Day, AS. Is orofacial granulomatosis in children a feature of Crohn’s disease. Acta Paediatr, 2005, 94: 501504.
140.Scully, C. Oral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment. Ed 3, Edinburgh: Churchill Livingstone, 2013, 298301.
141.Saalman, R, Sundell, S, Kullberg-Lindhc, C, et al. Long standing oral mucosal lesions in solid organ transplanted children – a novel clinical entity. Transplantation, 2010, 89: 606.
142.Williams, PM, Greenberg, MS. Management of cheilitis granulomatosa. Oral Surg, Oral Med, Oral Pathol, 1991, 72: 436439.
143.Kano, Y, Shiohara, T, Yagita, A, et al. Treatment of recalcitrant cheilitis granulomatosa with metronid. J. Am Acad Dermatol, 1992, 27: 629630 (a3.1).
144.Haverman, CW, Sloan, TB, Sloan, RT. Multiple endocrine neoplasia syndrome type III: review and case report. Spec Care Dentist, 1995, 15: 102106.
145.Pasquali, D, Matteo, FM, Renzullo, A, et al. Multiple endocrine neoplasia of the old and the new: mini review. G Ghir, 2012, 33: 370373.
146.Kahn, MA, Cote, J, Gagel, RE. RET proto-oncogene mutation analysis in multiple endocrine neoplasia syndrome type 2B. Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 82: 288294.
147.Raue, F, Frank-Raue, K. Multiple endocrine neoplasia type 2. Fam Cancer, 2010, 9: 449457.
148.Camacho, CP, Huff, AO, Lindsey, SC. Early diagnosis of multiple endocrine neoplasia syndrome type 2B. A challenge for physicians. Arq Bras Endocrine Metabol, 2008, 52: 13931398.
149.Fox, E, Widemann, BC, Ckuk, MK, et al. Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin Ca Res, 2013, 19: 42394248.
150.Mehta, A, Ricci, R, Widmer, U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. European J Clinic Invest, 2004, 34: 236242.
151.Gutierrez-Solana, LG. Advances in the treatment of lysosomal diseases in infancy. Rev Neural, 2006, 5:suppl 1: 137144.
152.Gorlin, RJ, Sedano, HO. Stomatologic aspects of cutaneous diseases: angiokeratoma corporis diffusum (Fabry syndrome). J Dermatol Surg Oncol, 1979, 5: 180181.
153.Altarescu, G, Berri, R, Eiges, R, et al. Prevention of lysosomal storage diseases and derivation of mutant stem cell liner by preimplantation genetic diagnosis. Mol Biol Int, 2012, doi 10.1155/2012/97342 Epub 2012, Dec 26.
154.Surjushe, A, Jindal, S, Sao, P, et al. Anderson-Fabrys disease with marfanoid features. Indian J Dermatol Venereol, 2008, 74: 389391.
155.Prasad, SS, Radharani, C, Sinna, S, et al. Hereditary gingival fibromatosis with distinctive facies. J Contemp Dent Pract, 2012, 1: 892896.
156.Shi, J, Lin, W, Li, X, et al. Hereditary gingival fibromatous a true generation case and pathologenic mechanism research on progress of the disease. J Periodontol, 2011, 82: 10891095.
157.Avelar, RL, deLana Campos, GJ, deCarvalho-Bezerra Falcao, PG, et al. Hereditary gingival fibromatosis: a report of four cases in the same family. Quintessence Int, 2010, 41: 99102.
158.Breen, GH, Adante, R, Black, CC. Early onset of hereditary gingival fibromatosis in a 28-month-old. Pediatr Dent, 2009, 31: 286288.
159.Martelli, H Jr, Santos, SM, Guimaraes, AL, et al. Idiopathic gingival fibromatosis: description of two cases. Minerva Stomatol, 2010, 59: 143148.
160.Byers, PH, Murray, ML, et al. Heritable collagen disorders. The paradigm of Ehlers Danlos syndrome. J Invest Dermatol, 2012, 15: E6E11. doi: 10.1038/skinbio.2012.3.
161.Eder, J, Laccone, F, Rohbach, M, et al. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV. Exp Dermatol, 2013, 22: 231234.
162.Mao, JR, Bristow, J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest, 2001, 107: 10631069.
163.Pinto, YM, Pals, G, Ziglstra, JG, et al. Ehlers-Danlos syndrome type IV. N Eng J Med, 2000, 343: 366368.
164.Yassin, OM, Rihani, FB. Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome. J Clin Pediatr Dent, 2006, 30: 337341.
165.Calva, D, Howe, JR. Hamartomatous polyposis syndromes. Surg Clin North Am, 2008, 88: 779817.
166.Brosens, LA, Van Hatley, WA, Jansen, M, et al. Gastrointestinal polyposis syndromes. Current Mol Med, 2007, 7: 2946.
167.Hinds, R, Philp, C, Hyer, W, et al. Complications of childhood Peutz-Jegher’s syndrome. Implications for pediatric screening. J Pediatr Gastroenteral Nutr, 2004, 39: 219220.
168.Mehenni, H, Blouin, JL, Radhakrishna, U, et al. Peutz-Jeghers syndrome: confirmation of a linkage to chromosome 19p13.3 and identification of a potential second locus on 19p13.4. Am J Hum Genet, 1997, 61: 13271334.
169.McCarity, TJ, Amos, C. Peutz-Jegher’s syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci, 2006, 63: 21352144.
170.Tovar, JA, Eizaquirre, I, Albert, A, et al. Peutz-Jegher’s syndroms in children: report of two cases and review of the literature. J Pediatr Surg, 1983, 18: 16.
171.Loeys, BL, Chen, J, Neptuine, ER. A syndroms of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 and TGFBR2. Nat Genet, 2005, 37: 275281.
172.Dean, JG. Marfan syndromes. Clinical diagnosis and management. European J Hum Genetics, 2007, 15: 724733.
173.deVries, BB, Pals, G, Odink, R, et al. Homozygosity for a FBN1 missence mutation clinical and molecular evidence for recessive Marfan syndrome. Eur J Hum Genet, 2007, 15: 930935.
174.Faivre, L, Gorlin, FJ, Wirtz, MK, et al. In frame fibrillin-1 gene deletion in autosomal dominant weill-marchesani syndrome. J Med Genet, 2003, 40: 3436.
175.Pyeitz, RE. The Marfan syndrome in childhood. Features, natural history and differential diagnosis. Prog Pediatric Cariol, 1996, 5: 151157.
176.Bolar, N, Van Laer, , Loeys, BL. Marfan syndrome: from gene to therapy. Curr Opin Pediatr, 2012, 24: 498504.
177.Cohen, MM Jr. Proteus syndrome: an update. Am J Med Genet C Seminar Med Genet, 2005, 137: 3852.
178.Hoey, SE, Eastwood, D, Monsell, , et al. Histopathological features of proteus syndrome. Clin Exp Dermatol, 2008, 33: 234238.
179.Happle, R. The manifold faces of proteus syndrome. Arch Dermatol, 2004, 140: 10011002.
180.Twede, JV, Turner, JT, Biesecker, LG, et al. Evolution of skin lesions in proteus syndrome. J Am Acad Dermatol, 2005, 52: 834838.
181.Cardoso, MT, deCarvalho, TB, Casulari, LA, et al. Proteus syndrome and somatic mosaigism of the chromosome 16. Panminerva Med, 2003, 45: 267271.
182.Lindhurst, MJ, Sapp, JC, Teer, JK, et al. A mosaic activating mutation in AKT1 associated with proteus syndrome. N Engl J Med, 2011, 365: 611619.
183.Bhupal, HK. Ramsay Hunt syndrome presenting in primary care. Practitioner, 2010, 254: 3335.
184.Kleinschmidt-DeMasters, BK, Gilden, DH. The expanding spectrum of herpes virus infections of the nervous system. Brainn Pthol, 2001, 11: 440451.
185.Sandoval, CC, Nunez, FA, Lizama, CM, et al. Ramsay Hunt syndrome in children: four cases and review. Rev Chilena Infectol, 2008, 25: 458464.
186.Ryer, EW, Lee, HY, Lee, SY, et al. Clinical manifestations and prognosis of patients with Ramsay Hunt syndrome. Am J Otolaryngol, 2011, 33: 313318.
187.Furuta, Y, Aizawa, H, Ohtani, F, et al. Varicella-Zoster virus reactivation on Ramsay Hunt syndrome. Ann Otol Rhinol Laryngol, 2004, 113: 700705.
188.Coffin, SE, Hodkinka, RL. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J Clin Microiol, 1995, 33: 27922795.
189.Naganawa, S, Nakashima, T. Cutting edge of inner ear MRI. Acta Otolaryngol Supp, 2009, 560: 1521.
190.Uscategui, T, Doree, C, Chamberlain, IJ, et al. Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Data Base System Review, Oct 8 2008, doi: 10.1002/14651858.
191.deRu, JA, VanBenthem, PP. Combination therapy is preferable for patients with Ramsay Hunt syndrome. Oto Neurotol, 2011, 32: 852855.
192.Albers–Schonberg, H. Roetgenbilder einer seltenen knochennerkrankung. Muuch Med Wochenschr, 1904, 51: 365.
193.Start, Z, Savarirayan, R. Osteopetrosis. Orphanet J Rare Dis, 2009, 4: 5.
194.Tritelbaum, SL. Bone resorption by osteoclasts. Science, 2000, 289: 15041508.
195.Wada, T, Nakashima, T, Oliveria-dos-Santos, , et al. The molecular scatfold Bag 2 is a critical component of RANK signaling and osteoclastogenesis. Nat Med, 2005, 11: 394399.
196.Cleiren, E, Benichou, O, VanHul, E, et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in CICN7 chloride channel gene. Hum Mol Genet, 2001, 10: 28612667.
197.Mazzolari, E, Forino, C, Razza, A, et al. A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol, 2009, 84: 473479.
198.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Chicago: Quintessence Publishing Company, 2012.
199.Symposium on osteopetrosis: proceedings and abstracts of the first interactive symposium on osteopetrosis: Biology and therapy. Oct 23–24, 2003, Bethesda Maryland. USA J Bone Miner Res, 2004, 19: 1356–1375.
200.Armstrong, DG, Newfield, JY, Gillespie, R. Orthopedic management of osteopetrosis: results of a survey and review of the literature. J Pediatr Orthop, 1999, 19: 122132.
201.Lata, PHJ, Sharma, R, Parmar, M. Massive osteolysis of hemimandible: a case report. J Maxillofac Oral Surg, 2009, 8: 381383.
202.Lee, S, Finn, L, Sze, RW. Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg, 2003, 129: 13401343.
203.Hu, P, Yuan, XG, Chan, XY, et al. Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature. J Zhejiang Univ Sci B, 2013, 14: 729735.
204.Ruggieri, P, Montalti, M, Angelini, A, et al. Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skeletal Radiol, 2011, 40: 13911397.
205.Dong, Q, Yafei, Z, Chuankong, S. Gorham-Stout syndrome affecting the left mandible: a case report. Exp Ther Med, 2013, 5: 162164.
206.Escande, C, Schouman, T, Francoise, G, et al. Histological features and management of a mandibular Gorham-Stout disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 106: e30e37.
207.Silva, S. Gorham-Stout disease affecting both hands: stabilization during bisphosphonate treatment. Hand (NY), 2011, 6: 8589.
208.Zheng, MW, Yang, M, Qiu, JX, et al. Gorham-Stout syndrome presenting in a 5-year-old girl with successful bisphosphonate therapeutic effect. Exp Ther Med, 2012, 4: 449451.
209.Nir, V, Guralnik, L, Livnat, G. Propranolol as a treatment option in Gorham-Stout syndrome. A case report. Pediatr Pulmonol, 2014, 49: 417419.
1.Baldwin, DJ, Thayalan, K, Amrita, J, et al. Glial choristoma of the tongue: report of a case and clinicopathological features. Int J of Pediatr Dent, 2009, 19: 219221.
2.Martinez-Peῆuela, A, Quer, S, Beloqui, R. Glial choristoma of the middle ear: report of 2 cases. Otology and Neurology, 2011, 32: e26e27.
3.Strome, SE, McClatchey, K, Kileny, PR, et al. Neonatal choristoma of the tongue containing glial tissue. Diagnostic and surgical considerations. Int J Pediatr Otorhino Laryngol, 1995, 33: 265273.
4.Sun, LS, Zhi-Peng, S, Xu-Chen, MA. Glial choristoma in the oral and maxillofacial region. A clinicopathologic study of 6 cases. Arch Pathol Lab Med, 2008, 132: 984998.
5.Fan, SQ, Ou, YM, Liang, QC. Glial choristoma of the tongue: report of a case and review of the literature. Pediatr Surg Int, 2008, 24: 515519.
6.Takamizawa, S, Inoue, T, Ono, Y, et al. A case report of glial choristoma of the tongue. J Pediatr Surg, 2006, 41: e13e15.
7.Fordyce, JA. A peculiar affection of the mucous membrane of the lips and oral cavity. J Cutan Dis, 1896, 14: 413419.
8.Lee, JH, Lee, JH, NA HK: Clinicopathologic manifestations of patients with Fordyce’s spots. Ann Dermatol, 2012, 24: 103106.
9.Oliver, JH. Fordyce granules on the prolabia and oral mucous membranes of a selected population. SADJ, 2006, 61: 7274.
10.DeFelice, C, Patrini, S, Chitano, G. et al. Fordyce granules and hereditary non-polyposis colorectal cancer syndrome. Gut, 2005, 41: 12791282.
11.Miller, AS, McCrea, MW. Sebaceous gland adenoma of the buccal mucosa. J Oral Surg, 1968, 26: 593595.
12.Miller, ML, Harford, RR, Yeager, JK. Fox Fordyce disease treated with topical clindamycin solution. Arch Dermatol, 1995, 131: 11121113.
13.Siggers, DC. Cleidocranial dysostosis. Dev Med Child Neurol, 1975, 4: 522524.
14.Shen, Z, Chio, C, Chun, Z, et al. Cleidocranial dysplasia: Report of 3 cases and literature review. Clinical Pediatrics, 2009, 2: 194198.
15.Bufalino, A, Paranaiba, LMR, Gouvêa, AF, et al. Cleidocranial dysplasia: oral features and genetic analysis of 11 patients. Oral Diseases, 2012, 18: 184190.
16.Ducy, P, Zhang, R, Geoffroy, V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997, 89: 747754.
17.Komori, T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res, 2010, 339: 189195.
18.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 231232.
19.Suda, N, Hattori, M, Kosaki, K, et al. Correlation between genotype and supernumerary tooth formation in cleidocranial dysplasia. Orthod Craniofac Res, 2010, 13: 197202.
20.Gorlin, RJ, Cohen, MN, Levin, LS. Syndromes of the Head and Neck. Ed 3, New York NY, Oxford University Press; 1990: 249253.
21.Jarvis, JL, Keats, TE. Cleidocranial dysostosis: a review of 40 new cases. Am J Roentgenol Radium Ther Nucl Med, 1974, 121: 516.
22.Perdigao, PF, Silva, ED, Sakurai, E, et al. Idiopathic bone cavity: a clinical, radiographic and histological study. Brit J Oral MG, 2003, 41: 407409.
23.Shigematsu, K, Fujita, W. Atypical simple bone cyst of the mandible. J Oral Maxillofac Surg, 1994, 23: 298299.
24.Manor, E, Kachko, L, Puterman, MB. Cystic lesions of the jaws: a clinicopathological study of 322 cases and review of the literature. Int J Med Sci, 2012, 9: 2026.
25.Patrikiou, A, Sepheriadouo-Mauropulou, G, Zambelis, G. Bilateral traumatic bone cysts of the mandible. Oral Surg, 1981, 51: 131133.
26.Zhu, L, Wang, X. Histological examination of the auricular cartilage and pseudocyst of the auricle. J Laryngol Otol, 1999, 106: 103104.
27.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 216217.
28.Velez, I, Siegel, MA, Mintz, SM et al. The relationship between idiopathic bone cavity and orthodontic tooth movement: analysis of 44 cases. Dentomaxillofac Radiol, 2010, 39: 162166.
29.Cortell-Ballester, I, Figueiredo, R, Berini-Aytes, L, et al. Traumatic bone cyst: a retrospective study of 21 cases. Med Oral Pathol Oral Cir Bucal 2009, 14: E239E243.
30.Kaffe, I, Littner, MM, Arensburg, B. The anterior buccal mandibular depression. Physical and radiologic features. Oral Surg Oral Med Oral Pathol, 1990, 69: 647654.
31.Apruzzese, D, Longoni, S. Stafne cyst in an anterior location. Oral Maxillofac Surg, 1999, 57: 333338.
32.Stafne, EC. Bone cavities situated near the angle of the mandible. J Am Dent Assoc, 1942, 29: 19691972.
33.Buchner, A, Carpenter, WM, Merrell, PW, et al. Anterior lingual salivary gland defect. Evaluation of twenty-four cases. Oral Surg Oral Med Oral Pathol, 1991, 71: 131136.
34.Shimizu, M, Osa, N, Okamura, K, et al. CT analysis of the Stafne’s bone defects of the mandible. Dentomaxillofac Radiol, 2006, 35: 95102.
35.Baughman, R. Testing your diagnostic skills. Case No. 2. Lingual mandibular salivary gland depression. Todays FDA, 2006, 18: 2023.
36.Sisman, Y, Miloglu, O, Sekerci, AE, et al. Radiographic evaluation of the prevalence of Stafne bone defect: a study from two centres in Turkey. Dentomaxillofacial Radiol, 2011, 35: 17.
37.Reye, RDK. A consideration of certain subdermal fibromatous tumors of infancy. J Pathol, 1956, 72: 149154.
38.Sotelo-Avilla, C, Bale, PM. Subdermal fibrous hamartomas of infancy: pathology of 40 cases and differential diagnosis. Pediatr Path, 1994, 14: 3952.
39.Paller, AS, Gonzalez-Grussi, F, Sherman, JO. Fibrous hamartomas of infancy: eight additional cases and a review of the literature. Arch Dermatol, 1989, 125: 8891.
40.Scott, DM, Pena, JR, Omura, E. Fibrous hamartomas of infancy. J Am Acad Dermatol, 1999, 41: 857858.
41.Westphal, SL, Bancila, E, Milgraum, SS. Fibrous hamartomas of infancy presenting as an inflamed epidermoid cyst. Pediatr Dermatol, 1990, 7: 157.
42.Boquot, JE, Gundlach, KKH. Odd tongues: the prevalence of common tongue lesions in 23,616 white Americans over 35 years of age. Quintessence Int, 1986, 17: 719730.
43.Ugar-Cankel, D, Denizci, S, Hocaoglu, J. Prevalence of tongue lesions among Turkish school children, Sandi Med, 2005, 26: 19621967.
44.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 99.
45.Mathew, AL, Pai, KM, Sholapurkar, AA, et al. The prevalence of oral mucosal lesions in patients visiting a dental school in Southern India. Indian J Dent Res, 2008, 19: 99103.
46.Koay, CL, Lim, JA, Siar, CH. The prevalence of tongue lesions in Malaysian dental out-patients from the Klang valley area. Oral Dis, 2011, 17: 210216.
47.Ohtani, J, Hoffman, WY, Vargevik, K. Team management and treatment outcomes for patients with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedies, 2012, 141: 574581.
48.Poswillo, D. The pathogenesis of first and second bronchial arch syndrome. Oral Surg, Oral Med, Oral Pathol, 1973, 35: 301328.
49.Kelberman, D, Tyson, DC, Chandler, AM, et al. Hemifacial microsomia: progress to understanding the genetic basis of a complex malformation syndrome. Hum Genet 2001, 109: 638645.
50.Pruzansky, S. Not all dwarfed mandibles are alike. Birth Defects, 1969, 4: 120129.
51.Cousley, RR A comparison of two classification systems for hemifacial microsomia. Br J Oral Maxillof Surg, 1993, 31: 7882.
52.Zanardi, G, Parente, EV, Esteves, LS. Orthodontic and surgical treatment of a patient with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedics, 2012, 141: 51305139.
53.Miranda, R, Barros, LM, Nogueira dos Santos, LA, et al. Clinical and imaging features in a patient with hemifacial hyperplasia. J Oral Sci, 2010, 52: 509512.
54.Bergman, JA. Primary hemifacial hypertrophy. Review and report of a case. Arch Otolaryngol, 1973, 97: 490494.
55.Yashimoto, H, Hano, H, Kobayashi, K, et al. Increased proliferative activity of osteoblasts in congenital hemifacial hypertrophy. Plast Reconstr Surg, 1998, 102: 16051610.
56.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Quintessence Publishing Company, 2012, 240
57.Islam, MN, Bhattacharyya, I, Ojha, J, et al. Comparison between true and partial hemifacial hypertrophy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 104: 501509.
58.Azevedo, RA, Veronica, FS, Sarmento, VA, et al. Hemifacial hyperplasia. A case report. Quintessence Int, 2005, 36: 483486.
59.Wisniewski, SA, Trzeciak, WH. A new mutation resulting in the truncation of the TRAF6-interacting domain of XEDAR: a possible novel cause of hypohidrotic ectodermal dysplasia. J Med Genet, 2012, 49: 499501.
60.Clarke, A. Hypohidrotic ectodermal dysplasia. J Med Genet, 1987, 24: 659663.
61.Subramaniam, P, Neeraja, G. Witkop’s tooth and nail syndrome: a multifaceted approach to dental management. J Indian Soc Pedod Prev Dent, 2008, 26: 2225.
62.Lamartine, J. Towards a new classification of ectodermal dysplasias. Cin Exp Dermatol, 2003, 28: 351355.
63.Priolo, M, Lagana, C. Ectodermal dysplasia a new clinical-genetic classification. J Med Genet, 2001, 38: 579585.
64.Guckes, AD, Brahim, JS, McCarthy, GR, et al. Using endosseous dental implants for patients with ectodermal dysplasia. JADA, 1991, 122: 5962.
65.Ekstrand, K, Thomsson, M. Ectodermal dysplasia with partial anodontia: prosthetic treatment with implant prosthesis. J Dent Child, 1988, 4: 282284.
66.Smith, RA, Vargervik, K, Kearns, G, et al. Placement of an endosseous implant in a growing child with ectodermal dysplasia. Oral Surg Oral Med Oral Pathol, 1993, 75: 669673.
67.Urzua, B, Ortega-Pento, , Morales-Bozo, et al. Defining a new candidate gene for amelogenesis imperfecta: from molecular genetics to biochemistry. Biochem Genet, 2011, 49: 104121.
68.Stephanopoulos, G, Garefalaki, E, Lyroudia, K. Genes and related proteins involved in amelogenesis imperfect. J Dent Res, 2005, 84: 11171126.
69.Weinmann, JP, Svobcda, JF, Woods, RW. Hereditary disturbances of enamel formation and calcification. J Am Dent Assoc, 1945, 32: 397418.
70.Chaudhary, M, Dixit, S, Singh, A. Amelogenesis imperfecta: reporting of a case and review of the literature. J Oral Maxillofac Pathol, 2009, 13: 7077.
71.Witkop, CJ Jr. Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification. J Oral Pathol Med, 1989, 17: 547543.
72.Schulze, C. Erbbedingte strukturanomalicin menschlicher zahne. Acta Genet Med Gemellol, 1957, 7: 231235.
73.Kinney, H, Pople, JA, Driessen, CH, et al. Intrafibrillar mineral may be absent in dentinogenesis imperfecta type II. J Dental Res, 2001, 1:80: 15551559.
74.Thofakura, SR, Mah, J, Srinivasan, R, et al. The non collagenous dentin matrix proteins are involved in dentinogenesis imperfecta type II. J Dent Res 2000, 79: 835839.
75.Bhandari, S, Pannu, K. Dentinogenesis imperfecta: a review and case report of a family over four generations. Indian J Dent Res, 2008, 19: 357361.
76.Shields, ED, Bixler, D, El-Kafrawy, AM. A proposed classification of heritable human dentin defect with a description of a new entity. Arch Oral Biol, 1973, 18: 543553.
77.Levin, LS, Leaf, SH, Jemini, RJ, et al. Dentinogenesis imperfecta in the Brandywine isolate hereditary opalescent dentin in an Ashkenazic Jewish family. Oral Surg Oral Med Oral Pathol, 1985, 59: 608615.
78.Von Marschall, Z, Mok, S, Phillips, MD. Rough endoplasmic reticulum trafficking errors by different classes of mutant dentin sialophosphorprotein (DSPP) causes dominant negative effects in both dentinogenesis imperfecta and dentin dysplasia by encapping normal DSPP. J Bone Miner Res, 2012, 27: 13091321.
79.Buday, K. Beiträge zar Lehre der osteogenesis imperfect, 1895.
80.Sillence, DO, Senn, A, Danks, DM. Genetic heterogenicity in osteogenesis imperfecta. J Med Genet, 1979, 16: 101116.
81.Rosen, A, Modig, M, Larson, O. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. Int J Oral Surg, 2011, 40: 866873.
82.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 232236.
83.Huber, MA. Osteogenesis imperfect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103: 314320.
84.Bergstrom, L. Osteogenesis imperfecta: otologic and maxillofacial aspects. Laryngoscope, 1977, 87: 142.
85.O’Connel, AC, Marini, JC. Evaluation of oral problems in an osteogenesis imperfect population. Oral SLurg Oral Med Oral Pathol Oral Radiol Endod, 1999, 87: 189196.
86.Kindelan, J, Tobin, M, Robert-Harry, RA. Orthodontic and orthognatic management of a patient with osteogenesis imperfect and dentinogenesis imperfect. A case report. J Orthod 2003, 30: 291296.
87.Marszalek, B, Wyojcicki, P, Kobus, K, et al. Clinical features, treatment and genetic background of Treacher Collins syndrome. J Appl Genet, 2002, 43: 223233.
88.Dixon, J, Edwards, SJ, Anderson, L. Identification of the complete coding sequence and genetic organization of the Treacher Collins syndrome gene. Genome Res, 1997, 7: 223234.
89.Rovin, S, Dachi, SF, Borenstein, DB, et al. Mandibulofacial dysostosis, a familial study of five generations. J Pediat, 1964, 65: 215221.
90.Jones, KL, Smith, DW, Harvey, MA, et al. Mandibulofacial dysostosis older paternal age and fresh gene mutation: data on additional disorders. J Pediat, 1975, 86: 8488.
91.LeMerrer, M, Cikuli, M, Ribier, J, et al. Acrofacial dysostosis. Am J Med Genet, 1989, 33: 318322.
92.Dixon, J, Trainor, MJ, Dixon, MJ. Treacher Collins syndrome. Orthodontics and Craniofacial Research, 2007, 10: 8895.
93.Horiuchi, K, Ariga, T, Fujioka, H, et al. Mutational analysis of the TCOF1 gene in 11 Japanese patients with Treacher Collins syndrome and mechanism of mutagenesis. J Med Genet, 2005, 134:363: 367.
94.Cohen, J, Ghezzi, F, Goncalves, L, et al. Prenatal sonographic diagnosis of Treacher Collins Syndrome: A case and review of the literature. Am J Perinatol, 1995, 12: 416419.
95.Cannon, AB. White nevus of the mucosa (naevus spongiosus albus mucosa) Arch Derm Syphiol, 1935, 31: 365373.
96.Hernandez-Martin, A, Fernandez-Lopez, E, deUnamuno, M. Diffuse whitening of the oral mucosa in a child. Pediatr Dermatol 1997, 14: 316320.
97.Naseem, S, Brady, R, McDonald, J. Diffuse white oral plaques. Clinical Infectious Diseases 2003, 36: 519520.
98.Jorgenson, RJ, Levin, LS. White sponge nevus. Arch Dermatol 1981, 117: 7376.
99.Allingham, RR, Seo, B, Rapersaud, E, et al. A duplication in chromosome 4q35 is associated with hereditary benign intraepithelial dyskeratosis. Am J Hum Genet 2001, 68: 491494.
100.Chao, SC, Tsai, Y-M, Yang, MH, et al. A novel mutation in the keratin 4 gene causing white sponge naevus. Br J Dermatol 2003, 184: 11251128.
101.Sadeghi, EM, Witkop, CJ. The presence of Candida albicans in hereditary benign intraepithelial dyskeratosis. An ultrastructural observation. Oral Surg Oral Med Oral Pathol 1979, 48: 342346.
102.Greer, RO Jr. Oral manifestations of smokeless tobacco use. Otolaryngologic Clinics of North America, 2010, 44: 3156.
103.Lim, J, Ng, S. Oral tetracycline rinse improves symptoms of white sponge nevus. J Am Acad Dermatol, 1992, 26: 10031005.
104.Elliott, M, Bayly, R, Cole, T, Temple, IK, Maher, ER. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clinical Genetics, 1994, 46, 168174.
105.Thorburn, MJ, Wright, ES, Miller, CG, Smith-Read, EHL. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. American J Diseases of Children, 1970, 119: 316321.
106.Pettenati, MJ, Haines, JL, Higgins, RR, Wappner, RS, Palmer, CG, Weaver, DD. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Human Genetics, 1986, 74: 143154.
107.DeBaun, MR, Niemitz, EL, McNeil, DE, Brandenburg, SA, Lee, MP, Feinberg, AP. Epigenetic alterations of H19 and L1T1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Human Genetics, 2002, 70: 604611.
108.Ullbro, C, Crossner, CG, Nederfors, T, Alfadley, A, Thestrup-Pedersen, K. Dermatological and oral findings in a cohort of 47 patients with Papillon-Lefevre syndrome. J Am Acad Dermatol, 2003, 48: 345351.
109.Cagli, NA, Hakki, SS, Darsun, R, et al. Clinical genetic, and biochemical findings in two siblings with Papillon-Lefévre syndrome. J Periodontal, 2005, 76: 23222329.
110.Wani, A, Devkar, N, Patole, M, Shouche, Y. Description of two new cathespin C gene mutations in patients with Papillon-Lefévre syndrome. J Peridontol, 2005, 76: 23222329.
111.Zadik, Y, Drucker, S, Pallmon, S. Migratory stomatitis (ectopic geographic tongue) on the floor of the mouth. J Am Acad Dermatol, 2011, 6: 459460.
112.Kvien, T, Glennas, A, Melby, K, Granfors, K, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatology, 1994, 21: 115122.
113.Hill Gaston, JS, Lillicrap, MS. Arthritis associated with enteric infection. Clinical Rheumatology, 2003, 17: 219239.
114.Suhanga, J, Chakshu, A, Mohideen, K, et al. Cherubism combined with epilepsy, mental retardation and gingival fibromatosis. (Ramon syndrome): a case report. Head and Neck Pathol, 2010, 4: 12131.
115.Ramon, Y, Berman, W, Bubus, JJ. Gingival fibromatosis combined with Cherubism. Oral Surg, Oral Med, Oral Pathol, 1967, 24: 436448.
116.Hall, G. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol, 2001, 112: 851862.
117.Kasabach, HH, Merritt, KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child, 1940, 59: 1063.
118.el-Dessouky, M, Azmy, A, Raine, P, Young, D. Kasabach-Merritt syndrome. J Pediatr Surg, 1998, 23: 109111.
119.Enjolras, O, Mulliken, J, Wassef, M, Frieden, I, Rieu, P, Burrows, P, Salhi, A, Léauté-Labrèze, C, Kozakewich, H. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol, 2000, 42: 224235.
120.Stone, J. Neurological rarity: Parry-Romberg syndrome. Practical Neurology, 2006, 6: 185188.
121.Leao, M, da Silva, ML. Progressive hemifacial atrophy with agenesis of the head and the caudate nucleus. J Med Genetics, 1994, 31: 969971.
122.Muchnik, RS, Aston, SJ, Rees, TD. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmology, 1979, 88: 889897.
123.Lewkonia, RM, Lowry, RB, Opitz, JM. Progressive hemifacial atrophy (Parry-Romberg syndrome): report with review of genetics and nosology. Am J Med Genetics, 1983, 14: 385390.
124.Inigo, F, Jimenez-Murat, Y, Arroyo, O, Fernandez, M, Ysunza, A. Restoration of facial contour in Romberg’s disease and hemifacial microsomia. Experience with 118 cases. Microsurgery, 2000, 20: 167172.
125.Shirley, MD, Tang, H, Gallione, CJ, et al. Sturge-Weber syndrome and Port-wine stains caused by somatic mutations in GNAQ. New England J Med, 2013, 368: 19711979.
126.Sturge, WA. A case of partial epilepsy, apparently due to a lesion of one of the vasomotor centres of the brain. Transactions of the Clinical Society of London, 1879, 12: 162.
127.Greenwood, M, Meechan, JG. General medicine and surgery for dental practitioners Part 4: Neurological disorders. Br Dent, 2003, 195: 1925.
128.Weber, FP. Right-sided hemi-hypertrophy resulting from right-sided congenital spastic hemiplegia, with a morbid condition of the left side of the brain, revealed by radiograms. J Neurology and Psychopathology (London), 1922, 3: 134139.
129.Kubota, M, Usami, I, Yamakawa, M, Tomita, Y, Haruta, T. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. J Paediatrics and Child Health, 2008, 44: 359362.
130.Scardina, GA, Fucà, G, Carini, F, et al. Oral necrotizing microvasculitis in a patient affected by Kawasaki disease. Medicina Oral, Patologia Oral Y Cirugia Buc, 2007, 12: E560E564.
131.Do, JH, Baek, JG, Kim, HJ, et al. Kawasaki disease presenting as parotitis in a 3 month old infant. Korean Circulation Journal, 2009, 39: 502504.
132.Michie, C, Kinsler, V, Tulloh, R, Davidson, S. Recurrent skin peeling following Kawasaki disease. Archives of Disease in Childhood, 2000, 83: 353355.
133.Gardner, EJ, Richards, RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet, 1953, 5: 139147.
134.Knudsen, AL, Bisguard, ML, Bűlow, S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer, 2003, 2: 4355.
135.Miyoshi, Y, Nagase, H, Ando, H, et al. Somatic mutations of the APC gene in colorectal tumors. Mutation in the cluster region in the APC gene. Hum Mol Genet, 1992, 1: 229233.
136.Saurin, JC, Chayvialle, JA, Ponchon, T. Management of duodenal adenomas in familial adenomatous polyposis. Fam Cancer, 2008, 7: 173177.
137.Lourenco, SV, Boggio, P, Suquyama, K, et al. Severe and relapsing upper lip enlargement in a 10 year old boy. Acta Paediatr, 2010, 99: 1958.
138.Rogers RS, . Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin, 1996, 14: 371379.
139.Khouri, JM, Bohane, TD, Day, AS. Is orofacial granulomatosis in children a feature of Crohn’s disease. Acta Paediatr, 2005, 94: 501504.
140.Scully, C. Oral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment. Ed 3, Edinburgh: Churchill Livingstone, 2013, 298301.
141.Saalman, R, Sundell, S, Kullberg-Lindhc, C, et al. Long standing oral mucosal lesions in solid organ transplanted children – a novel clinical entity. Transplantation, 2010, 89: 606.
142.Williams, PM, Greenberg, MS. Management of cheilitis granulomatosa. Oral Surg, Oral Med, Oral Pathol, 1991, 72: 436439.
143.Kano, Y, Shiohara, T, Yagita, A, et al. Treatment of recalcitrant cheilitis granulomatosa with metronid. J. Am Acad Dermatol, 1992, 27: 629630 (a3.1).
144.Haverman, CW, Sloan, TB, Sloan, RT. Multiple endocrine neoplasia syndrome type III: review and case report. Spec Care Dentist, 1995, 15: 102106.
145.Pasquali, D, Matteo, FM, Renzullo, A, et al. Multiple endocrine neoplasia of the old and the new: mini review. G Ghir, 2012, 33: 370373.
146.Kahn, MA, Cote, J, Gagel, RE. RET proto-oncogene mutation analysis in multiple endocrine neoplasia syndrome type 2B. Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 82: 288294.
147.Raue, F, Frank-Raue, K. Multiple endocrine neoplasia type 2. Fam Cancer, 2010, 9: 449457.
148.Camacho, CP, Huff, AO, Lindsey, SC. Early diagnosis of multiple endocrine neoplasia syndrome type 2B. A challenge for physicians. Arq Bras Endocrine Metabol, 2008, 52: 13931398.
149.Fox, E, Widemann, BC, Ckuk, MK, et al. Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin Ca Res, 2013, 19: 42394248.
150.Mehta, A, Ricci, R, Widmer, U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. European J Clinic Invest, 2004, 34: 236242.
151.Gutierrez-Solana, LG. Advances in the treatment of lysosomal diseases in infancy. Rev Neural, 2006, 5:suppl 1: 137144.
152.Gorlin, RJ, Sedano, HO. Stomatologic aspects of cutaneous diseases: angiokeratoma corporis diffusum (Fabry syndrome). J Dermatol Surg Oncol, 1979, 5: 180181.
153.Altarescu, G, Berri, R, Eiges, R, et al. Prevention of lysosomal storage diseases and derivation of mutant stem cell liner by preimplantation genetic diagnosis. Mol Biol Int, 2012, doi 10.1155/2012/97342 Epub 2012, Dec 26.
154.Surjushe, A, Jindal, S, Sao, P, et al. Anderson-Fabrys disease with marfanoid features. Indian J Dermatol Venereol, 2008, 74: 389391.
155.Prasad, SS, Radharani, C, Sinna, S, et al. Hereditary gingival fibromatosis with distinctive facies. J Contemp Dent Pract, 2012, 1: 892896.
156.Shi, J, Lin, W, Li, X, et al. Hereditary gingival fibromatous a true generation case and pathologenic mechanism research on progress of the disease. J Periodontol, 2011, 82: 10891095.
157.Avelar, RL, deLana Campos, GJ, deCarvalho-Bezerra Falcao, PG, et al. Hereditary gingival fibromatosis: a report of four cases in the same family. Quintessence Int, 2010, 41: 99102.
158.Breen, GH, Adante, R, Black, CC. Early onset of hereditary gingival fibromatosis in a 28-month-old. Pediatr Dent, 2009, 31: 286288.
159.Martelli, H Jr, Santos, SM, Guimaraes, AL, et al. Idiopathic gingival fibromatosis: description of two cases. Minerva Stomatol, 2010, 59: 143148.
160.Byers, PH, Murray, ML, et al. Heritable collagen disorders. The paradigm of Ehlers Danlos syndrome. J Invest Dermatol, 2012, 15: E6E11. doi: 10.1038/skinbio.2012.3.
161.Eder, J, Laccone, F, Rohbach, M, et al. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV. Exp Dermatol, 2013, 22: 231234.
162.Mao, JR, Bristow, J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest, 2001, 107: 10631069.
163.Pinto, YM, Pals, G, Ziglstra, JG, et al. Ehlers-Danlos syndrome type IV. N Eng J Med, 2000, 343: 366368.
164.Yassin, OM, Rihani, FB. Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome. J Clin Pediatr Dent, 2006, 30: 337341.
165.Calva, D, Howe, JR. Hamartomatous polyposis syndromes. Surg Clin North Am, 2008, 88: 779817.
166.Brosens, LA, Van Hatley, WA, Jansen, M, et al. Gastrointestinal polyposis syndromes. Current Mol Med, 2007, 7: 2946.
167.Hinds, R, Philp, C, Hyer, W, et al. Complications of childhood Peutz-Jegher’s syndrome. Implications for pediatric screening. J Pediatr Gastroenteral Nutr, 2004, 39: 219220.
168.Mehenni, H, Blouin, JL, Radhakrishna, U, et al. Peutz-Jeghers syndrome: confirmation of a linkage to chromosome 19p13.3 and identification of a potential second locus on 19p13.4. Am J Hum Genet, 1997, 61: 13271334.
169.McCarity, TJ, Amos, C. Peutz-Jegher’s syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci, 2006, 63: 21352144.
170.Tovar, JA, Eizaquirre, I, Albert, A, et al. Peutz-Jegher’s syndroms in children: report of two cases and review of the literature. J Pediatr Surg, 1983, 18: 16.
171.Loeys, BL, Chen, J, Neptuine, ER. A syndroms of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 and TGFBR2. Nat Genet, 2005, 37: 275281.
172.Dean, JG. Marfan syndromes. Clinical diagnosis and management. European J Hum Genetics, 2007, 15: 724733.
173.deVries, BB, Pals, G, Odink, R, et al. Homozygosity for a FBN1 missence mutation clinical and molecular evidence for recessive Marfan syndrome. Eur J Hum Genet, 2007, 15: 930935.
174.Faivre, L, Gorlin, FJ, Wirtz, MK, et al. In frame fibrillin-1 gene deletion in autosomal dominant weill-marchesani syndrome. J Med Genet, 2003, 40: 3436.
175.Pyeitz, RE. The Marfan syndrome in childhood. Features, natural history and differential diagnosis. Prog Pediatric Cariol, 1996, 5: 151157.
176.Bolar, N, Van Laer, , Loeys, BL. Marfan syndrome: from gene to therapy. Curr Opin Pediatr, 2012, 24: 498504.
177.Cohen, MM Jr. Proteus syndrome: an update. Am J Med Genet C Seminar Med Genet, 2005, 137: 3852.
178.Hoey, SE, Eastwood, D, Monsell, , et al. Histopathological features of proteus syndrome. Clin Exp Dermatol, 2008, 33: 234238.
179.Happle, R. The manifold faces of proteus syndrome. Arch Dermatol, 2004, 140: 10011002.
180.Twede, JV, Turner, JT, Biesecker, LG, et al. Evolution of skin lesions in proteus syndrome. J Am Acad Dermatol, 2005, 52: 834838.
181.Cardoso, MT, deCarvalho, TB, Casulari, LA, et al. Proteus syndrome and somatic mosaigism of the chromosome 16. Panminerva Med, 2003, 45: 267271.
182.Lindhurst, MJ, Sapp, JC, Teer, JK, et al. A mosaic activating mutation in AKT1 associated with proteus syndrome. N Engl J Med, 2011, 365: 611619.
183.Bhupal, HK. Ramsay Hunt syndrome presenting in primary care. Practitioner, 2010, 254: 3335.
184.Kleinschmidt-DeMasters, BK, Gilden, DH. The expanding spectrum of herpes virus infections of the nervous system. Brainn Pthol, 2001, 11: 440451.
185.Sandoval, CC, Nunez, FA, Lizama, CM, et al. Ramsay Hunt syndrome in children: four cases and review. Rev Chilena Infectol, 2008, 25: 458464.
186.Ryer, EW, Lee, HY, Lee, SY, et al. Clinical manifestations and prognosis of patients with Ramsay Hunt syndrome. Am J Otolaryngol, 2011, 33: 313318.
187.Furuta, Y, Aizawa, H, Ohtani, F, et al. Varicella-Zoster virus reactivation on Ramsay Hunt syndrome. Ann Otol Rhinol Laryngol, 2004, 113: 700705.
188.Coffin, SE, Hodkinka, RL. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J Clin Microiol, 1995, 33: 27922795.
189.Naganawa, S, Nakashima, T. Cutting edge of inner ear MRI. Acta Otolaryngol Supp, 2009, 560: 1521.
190.Uscategui, T, Doree, C, Chamberlain, IJ, et al. Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Data Base System Review, Oct 8 2008, doi: 10.1002/14651858.
191.deRu, JA, VanBenthem, PP. Combination therapy is preferable for patients with Ramsay Hunt syndrome. Oto Neurotol, 2011, 32: 852855.
192.Albers–Schonberg, H. Roetgenbilder einer seltenen knochennerkrankung. Muuch Med Wochenschr, 1904, 51: 365.
193.Start, Z, Savarirayan, R. Osteopetrosis. Orphanet J Rare Dis, 2009, 4: 5.
194.Tritelbaum, SL. Bone resorption by osteoclasts. Science, 2000, 289: 15041508.
195.Wada, T, Nakashima, T, Oliveria-dos-Santos, , et al. The molecular scatfold Bag 2 is a critical component of RANK signaling and osteoclastogenesis. Nat Med, 2005, 11: 394399.
196.Cleiren, E, Benichou, O, VanHul, E, et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in CICN7 chloride channel gene. Hum Mol Genet, 2001, 10: 28612667.
197.Mazzolari, E, Forino, C, Razza, A, et al. A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol, 2009, 84: 473479.
198.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Chicago: Quintessence Publishing Company, 2012.
199.Symposium on osteopetrosis: proceedings and abstracts of the first interactive symposium on osteopetrosis: Biology and therapy. Oct 23–24, 2003, Bethesda Maryland. USA J Bone Miner Res, 2004, 19: 1356–1375.
200.Armstrong, DG, Newfield, JY, Gillespie, R. Orthopedic management of osteopetrosis: results of a survey and review of the literature. J Pediatr Orthop, 1999, 19: 122132.
201.Lata, PHJ, Sharma, R, Parmar, M. Massive osteolysis of hemimandible: a case report. J Maxillofac Oral Surg, 2009, 8: 381383.
202.Lee, S, Finn, L, Sze, RW. Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg, 2003, 129: 13401343.
203.Hu, P, Yuan, XG, Chan, XY, et al. Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature. J Zhejiang Univ Sci B, 2013, 14: 729735.
204.Ruggieri, P, Montalti, M, Angelini, A, et al. Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skeletal Radiol, 2011, 40: 13911397.
205.Dong, Q, Yafei, Z, Chuankong, S. Gorham-Stout syndrome affecting the left mandible: a case report. Exp Ther Med, 2013, 5: 162164.
206.Escande, C, Schouman, T, Francoise, G, et al. Histological features and management of a mandibular Gorham-Stout disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 106: e30e37.
207.Silva, S. Gorham-Stout disease affecting both hands: stabilization during bisphosphonate treatment. Hand (NY), 2011, 6: 8589.
208.Zheng, MW, Yang, M, Qiu, JX, et al. Gorham-Stout syndrome presenting in a 5-year-old girl with successful bisphosphonate therapeutic effect. Exp Ther Med, 2012, 4: 449451.
209.Nir, V, Guralnik, L, Livnat, G. Propranolol as a treatment option in Gorham-Stout syndrome. A case report. Pediatr Pulmonol, 2014, 49: 417419.
1.Baldwin, DJ, Thayalan, K, Amrita, J, et al. Glial choristoma of the tongue: report of a case and clinicopathological features. Int J of Pediatr Dent, 2009, 19: 219221.
2.Martinez-Peῆuela, A, Quer, S, Beloqui, R. Glial choristoma of the middle ear: report of 2 cases. Otology and Neurology, 2011, 32: e26e27.
3.Strome, SE, McClatchey, K, Kileny, PR, et al. Neonatal choristoma of the tongue containing glial tissue. Diagnostic and surgical considerations. Int J Pediatr Otorhino Laryngol, 1995, 33: 265273.
4.Sun, LS, Zhi-Peng, S, Xu-Chen, MA. Glial choristoma in the oral and maxillofacial region. A clinicopathologic study of 6 cases. Arch Pathol Lab Med, 2008, 132: 984998.
5.Fan, SQ, Ou, YM, Liang, QC. Glial choristoma of the tongue: report of a case and review of the literature. Pediatr Surg Int, 2008, 24: 515519.
6.Takamizawa, S, Inoue, T, Ono, Y, et al. A case report of glial choristoma of the tongue. J Pediatr Surg, 2006, 41: e13e15.
7.Fordyce, JA. A peculiar affection of the mucous membrane of the lips and oral cavity. J Cutan Dis, 1896, 14: 413419.
8.Lee, JH, Lee, JH, NA HK: Clinicopathologic manifestations of patients with Fordyce’s spots. Ann Dermatol, 2012, 24: 103106.
9.Oliver, JH. Fordyce granules on the prolabia and oral mucous membranes of a selected population. SADJ, 2006, 61: 7274.
10.DeFelice, C, Patrini, S, Chitano, G. et al. Fordyce granules and hereditary non-polyposis colorectal cancer syndrome. Gut, 2005, 41: 12791282.
11.Miller, AS, McCrea, MW. Sebaceous gland adenoma of the buccal mucosa. J Oral Surg, 1968, 26: 593595.
12.Miller, ML, Harford, RR, Yeager, JK. Fox Fordyce disease treated with topical clindamycin solution. Arch Dermatol, 1995, 131: 11121113.
13.Siggers, DC. Cleidocranial dysostosis. Dev Med Child Neurol, 1975, 4: 522524.
14.Shen, Z, Chio, C, Chun, Z, et al. Cleidocranial dysplasia: Report of 3 cases and literature review. Clinical Pediatrics, 2009, 2: 194198.
15.Bufalino, A, Paranaiba, LMR, Gouvêa, AF, et al. Cleidocranial dysplasia: oral features and genetic analysis of 11 patients. Oral Diseases, 2012, 18: 184190.
16.Ducy, P, Zhang, R, Geoffroy, V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997, 89: 747754.
17.Komori, T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res, 2010, 339: 189195.
18.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 231232.
19.Suda, N, Hattori, M, Kosaki, K, et al. Correlation between genotype and supernumerary tooth formation in cleidocranial dysplasia. Orthod Craniofac Res, 2010, 13: 197202.
20.Gorlin, RJ, Cohen, MN, Levin, LS. Syndromes of the Head and Neck. Ed 3, New York NY, Oxford University Press; 1990: 249253.
21.Jarvis, JL, Keats, TE. Cleidocranial dysostosis: a review of 40 new cases. Am J Roentgenol Radium Ther Nucl Med, 1974, 121: 516.
22.Perdigao, PF, Silva, ED, Sakurai, E, et al. Idiopathic bone cavity: a clinical, radiographic and histological study. Brit J Oral MG, 2003, 41: 407409.
23.Shigematsu, K, Fujita, W. Atypical simple bone cyst of the mandible. J Oral Maxillofac Surg, 1994, 23: 298299.
24.Manor, E, Kachko, L, Puterman, MB. Cystic lesions of the jaws: a clinicopathological study of 322 cases and review of the literature. Int J Med Sci, 2012, 9: 2026.
25.Patrikiou, A, Sepheriadouo-Mauropulou, G, Zambelis, G. Bilateral traumatic bone cysts of the mandible. Oral Surg, 1981, 51: 131133.
26.Zhu, L, Wang, X. Histological examination of the auricular cartilage and pseudocyst of the auricle. J Laryngol Otol, 1999, 106: 103104.
27.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 216217.
28.Velez, I, Siegel, MA, Mintz, SM et al. The relationship between idiopathic bone cavity and orthodontic tooth movement: analysis of 44 cases. Dentomaxillofac Radiol, 2010, 39: 162166.
29.Cortell-Ballester, I, Figueiredo, R, Berini-Aytes, L, et al. Traumatic bone cyst: a retrospective study of 21 cases. Med Oral Pathol Oral Cir Bucal 2009, 14: E239E243.
30.Kaffe, I, Littner, MM, Arensburg, B. The anterior buccal mandibular depression. Physical and radiologic features. Oral Surg Oral Med Oral Pathol, 1990, 69: 647654.
31.Apruzzese, D, Longoni, S. Stafne cyst in an anterior location. Oral Maxillofac Surg, 1999, 57: 333338.
32.Stafne, EC. Bone cavities situated near the angle of the mandible. J Am Dent Assoc, 1942, 29: 19691972.
33.Buchner, A, Carpenter, WM, Merrell, PW, et al. Anterior lingual salivary gland defect. Evaluation of twenty-four cases. Oral Surg Oral Med Oral Pathol, 1991, 71: 131136.
34.Shimizu, M, Osa, N, Okamura, K, et al. CT analysis of the Stafne’s bone defects of the mandible. Dentomaxillofac Radiol, 2006, 35: 95102.
35.Baughman, R. Testing your diagnostic skills. Case No. 2. Lingual mandibular salivary gland depression. Todays FDA, 2006, 18: 2023.
36.Sisman, Y, Miloglu, O, Sekerci, AE, et al. Radiographic evaluation of the prevalence of Stafne bone defect: a study from two centres in Turkey. Dentomaxillofacial Radiol, 2011, 35: 17.
37.Reye, RDK. A consideration of certain subdermal fibromatous tumors of infancy. J Pathol, 1956, 72: 149154.
38.Sotelo-Avilla, C, Bale, PM. Subdermal fibrous hamartomas of infancy: pathology of 40 cases and differential diagnosis. Pediatr Path, 1994, 14: 3952.
39.Paller, AS, Gonzalez-Grussi, F, Sherman, JO. Fibrous hamartomas of infancy: eight additional cases and a review of the literature. Arch Dermatol, 1989, 125: 8891.
40.Scott, DM, Pena, JR, Omura, E. Fibrous hamartomas of infancy. J Am Acad Dermatol, 1999, 41: 857858.
41.Westphal, SL, Bancila, E, Milgraum, SS. Fibrous hamartomas of infancy presenting as an inflamed epidermoid cyst. Pediatr Dermatol, 1990, 7: 157.
42.Boquot, JE, Gundlach, KKH. Odd tongues: the prevalence of common tongue lesions in 23,616 white Americans over 35 years of age. Quintessence Int, 1986, 17: 719730.
43.Ugar-Cankel, D, Denizci, S, Hocaoglu, J. Prevalence of tongue lesions among Turkish school children, Sandi Med, 2005, 26: 19621967.
44.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 99.
45.Mathew, AL, Pai, KM, Sholapurkar, AA, et al. The prevalence of oral mucosal lesions in patients visiting a dental school in Southern India. Indian J Dent Res, 2008, 19: 99103.
46.Koay, CL, Lim, JA, Siar, CH. The prevalence of tongue lesions in Malaysian dental out-patients from the Klang valley area. Oral Dis, 2011, 17: 210216.
47.Ohtani, J, Hoffman, WY, Vargevik, K. Team management and treatment outcomes for patients with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedies, 2012, 141: 574581.
48.Poswillo, D. The pathogenesis of first and second bronchial arch syndrome. Oral Surg, Oral Med, Oral Pathol, 1973, 35: 301328.
49.Kelberman, D, Tyson, DC, Chandler, AM, et al. Hemifacial microsomia: progress to understanding the genetic basis of a complex malformation syndrome. Hum Genet 2001, 109: 638645.
50.Pruzansky, S. Not all dwarfed mandibles are alike. Birth Defects, 1969, 4: 120129.
51.Cousley, RR A comparison of two classification systems for hemifacial microsomia. Br J Oral Maxillof Surg, 1993, 31: 7882.
52.Zanardi, G, Parente, EV, Esteves, LS. Orthodontic and surgical treatment of a patient with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedics, 2012, 141: 51305139.
53.Miranda, R, Barros, LM, Nogueira dos Santos, LA, et al. Clinical and imaging features in a patient with hemifacial hyperplasia. J Oral Sci, 2010, 52: 509512.
54.Bergman, JA. Primary hemifacial hypertrophy. Review and report of a case. Arch Otolaryngol, 1973, 97: 490494.
55.Yashimoto, H, Hano, H, Kobayashi, K, et al. Increased proliferative activity of osteoblasts in congenital hemifacial hypertrophy. Plast Reconstr Surg, 1998, 102: 16051610.
56.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Quintessence Publishing Company, 2012, 240
57.Islam, MN, Bhattacharyya, I, Ojha, J, et al. Comparison between true and partial hemifacial hypertrophy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 104: 501509.
58.Azevedo, RA, Veronica, FS, Sarmento, VA, et al. Hemifacial hyperplasia. A case report. Quintessence Int, 2005, 36: 483486.
59.Wisniewski, SA, Trzeciak, WH. A new mutation resulting in the truncation of the TRAF6-interacting domain of XEDAR: a possible novel cause of hypohidrotic ectodermal dysplasia. J Med Genet, 2012, 49: 499501.
60.Clarke, A. Hypohidrotic ectodermal dysplasia. J Med Genet, 1987, 24: 659663.
61.Subramaniam, P, Neeraja, G. Witkop’s tooth and nail syndrome: a multifaceted approach to dental management. J Indian Soc Pedod Prev Dent, 2008, 26: 2225.
62.Lamartine, J. Towards a new classification of ectodermal dysplasias. Cin Exp Dermatol, 2003, 28: 351355.
63.Priolo, M, Lagana, C. Ectodermal dysplasia a new clinical-genetic classification. J Med Genet, 2001, 38: 579585.
64.Guckes, AD, Brahim, JS, McCarthy, GR, et al. Using endosseous dental implants for patients with ectodermal dysplasia. JADA, 1991, 122: 5962.
65.Ekstrand, K, Thomsson, M. Ectodermal dysplasia with partial anodontia: prosthetic treatment with implant prosthesis. J Dent Child, 1988, 4: 282284.
66.Smith, RA, Vargervik, K, Kearns, G, et al. Placement of an endosseous implant in a growing child with ectodermal dysplasia. Oral Surg Oral Med Oral Pathol, 1993, 75: 669673.
67.Urzua, B, Ortega-Pento, , Morales-Bozo, et al. Defining a new candidate gene for amelogenesis imperfecta: from molecular genetics to biochemistry. Biochem Genet, 2011, 49: 104121.
68.Stephanopoulos, G, Garefalaki, E, Lyroudia, K. Genes and related proteins involved in amelogenesis imperfect. J Dent Res, 2005, 84: 11171126.
69.Weinmann, JP, Svobcda, JF, Woods, RW. Hereditary disturbances of enamel formation and calcification. J Am Dent Assoc, 1945, 32: 397418.
70.Chaudhary, M, Dixit, S, Singh, A. Amelogenesis imperfecta: reporting of a case and review of the literature. J Oral Maxillofac Pathol, 2009, 13: 7077.
71.Witkop, CJ Jr. Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification. J Oral Pathol Med, 1989, 17: 547543.
72.Schulze, C. Erbbedingte strukturanomalicin menschlicher zahne. Acta Genet Med Gemellol, 1957, 7: 231235.
73.Kinney, H, Pople, JA, Driessen, CH, et al. Intrafibrillar mineral may be absent in dentinogenesis imperfecta type II. J Dental Res, 2001, 1:80: 15551559.
74.Thofakura, SR, Mah, J, Srinivasan, R, et al. The non collagenous dentin matrix proteins are involved in dentinogenesis imperfecta type II. J Dent Res 2000, 79: 835839.
75.Bhandari, S, Pannu, K. Dentinogenesis imperfecta: a review and case report of a family over four generations. Indian J Dent Res, 2008, 19: 357361.
76.Shields, ED, Bixler, D, El-Kafrawy, AM. A proposed classification of heritable human dentin defect with a description of a new entity. Arch Oral Biol, 1973, 18: 543553.
77.Levin, LS, Leaf, SH, Jemini, RJ, et al. Dentinogenesis imperfecta in the Brandywine isolate hereditary opalescent dentin in an Ashkenazic Jewish family. Oral Surg Oral Med Oral Pathol, 1985, 59: 608615.
78.Von Marschall, Z, Mok, S, Phillips, MD. Rough endoplasmic reticulum trafficking errors by different classes of mutant dentin sialophosphorprotein (DSPP) causes dominant negative effects in both dentinogenesis imperfecta and dentin dysplasia by encapping normal DSPP. J Bone Miner Res, 2012, 27: 13091321.
79.Buday, K. Beiträge zar Lehre der osteogenesis imperfect, 1895.
80.Sillence, DO, Senn, A, Danks, DM. Genetic heterogenicity in osteogenesis imperfecta. J Med Genet, 1979, 16: 101116.
81.Rosen, A, Modig, M, Larson, O. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. Int J Oral Surg, 2011, 40: 866873.
82.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 232236.
83.Huber, MA. Osteogenesis imperfect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103: 314320.
84.Bergstrom, L. Osteogenesis imperfecta: otologic and maxillofacial aspects. Laryngoscope, 1977, 87: 142.
85.O’Connel, AC, Marini, JC. Evaluation of oral problems in an osteogenesis imperfect population. Oral SLurg Oral Med Oral Pathol Oral Radiol Endod, 1999, 87: 189196.
86.Kindelan, J, Tobin, M, Robert-Harry, RA. Orthodontic and orthognatic management of a patient with osteogenesis imperfect and dentinogenesis imperfect. A case report. J Orthod 2003, 30: 291296.
87.Marszalek, B, Wyojcicki, P, Kobus, K, et al. Clinical features, treatment and genetic background of Treacher Collins syndrome. J Appl Genet, 2002, 43: 223233.
88.Dixon, J, Edwards, SJ, Anderson, L. Identification of the complete coding sequence and genetic organization of the Treacher Collins syndrome gene. Genome Res, 1997, 7: 223234.
89.Rovin, S, Dachi, SF, Borenstein, DB, et al. Mandibulofacial dysostosis, a familial study of five generations. J Pediat, 1964, 65: 215221.
90.Jones, KL, Smith, DW, Harvey, MA, et al. Mandibulofacial dysostosis older paternal age and fresh gene mutation: data on additional disorders. J Pediat, 1975, 86: 8488.
91.LeMerrer, M, Cikuli, M, Ribier, J, et al. Acrofacial dysostosis. Am J Med Genet, 1989, 33: 318322.
92.Dixon, J, Trainor, MJ, Dixon, MJ. Treacher Collins syndrome. Orthodontics and Craniofacial Research, 2007, 10: 8895.
93.Horiuchi, K, Ariga, T, Fujioka, H, et al. Mutational analysis of the TCOF1 gene in 11 Japanese patients with Treacher Collins syndrome and mechanism of mutagenesis. J Med Genet, 2005, 134:363: 367.
94.Cohen, J, Ghezzi, F, Goncalves, L, et al. Prenatal sonographic diagnosis of Treacher Collins Syndrome: A case and review of the literature. Am J Perinatol, 1995, 12: 416419.
95.Cannon, AB. White nevus of the mucosa (naevus spongiosus albus mucosa) Arch Derm Syphiol, 1935, 31: 365373.
96.Hernandez-Martin, A, Fernandez-Lopez, E, deUnamuno, M. Diffuse whitening of the oral mucosa in a child. Pediatr Dermatol 1997, 14: 316320.
97.Naseem, S, Brady, R, McDonald, J. Diffuse white oral plaques. Clinical Infectious Diseases 2003, 36: 519520.
98.Jorgenson, RJ, Levin, LS. White sponge nevus. Arch Dermatol 1981, 117: 7376.
99.Allingham, RR, Seo, B, Rapersaud, E, et al. A duplication in chromosome 4q35 is associated with hereditary benign intraepithelial dyskeratosis. Am J Hum Genet 2001, 68: 491494.
100.Chao, SC, Tsai, Y-M, Yang, MH, et al. A novel mutation in the keratin 4 gene causing white sponge naevus. Br J Dermatol 2003, 184: 11251128.
101.Sadeghi, EM, Witkop, CJ. The presence of Candida albicans in hereditary benign intraepithelial dyskeratosis. An ultrastructural observation. Oral Surg Oral Med Oral Pathol 1979, 48: 342346.
102.Greer, RO Jr. Oral manifestations of smokeless tobacco use. Otolaryngologic Clinics of North America, 2010, 44: 3156.
103.Lim, J, Ng, S. Oral tetracycline rinse improves symptoms of white sponge nevus. J Am Acad Dermatol, 1992, 26: 10031005.
104.Elliott, M, Bayly, R, Cole, T, Temple, IK, Maher, ER. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clinical Genetics, 1994, 46, 168174.
105.Thorburn, MJ, Wright, ES, Miller, CG, Smith-Read, EHL. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. American J Diseases of Children, 1970, 119: 316321.
106.Pettenati, MJ, Haines, JL, Higgins, RR, Wappner, RS, Palmer, CG, Weaver, DD. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Human Genetics, 1986, 74: 143154.
107.DeBaun, MR, Niemitz, EL, McNeil, DE, Brandenburg, SA, Lee, MP, Feinberg, AP. Epigenetic alterations of H19 and L1T1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Human Genetics, 2002, 70: 604611.
108.Ullbro, C, Crossner, CG, Nederfors, T, Alfadley, A, Thestrup-Pedersen, K. Dermatological and oral findings in a cohort of 47 patients with Papillon-Lefevre syndrome. J Am Acad Dermatol, 2003, 48: 345351.
109.Cagli, NA, Hakki, SS, Darsun, R, et al. Clinical genetic, and biochemical findings in two siblings with Papillon-Lefévre syndrome. J Periodontal, 2005, 76: 23222329.
110.Wani, A, Devkar, N, Patole, M, Shouche, Y. Description of two new cathespin C gene mutations in patients with Papillon-Lefévre syndrome. J Peridontol, 2005, 76: 23222329.
111.Zadik, Y, Drucker, S, Pallmon, S. Migratory stomatitis (ectopic geographic tongue) on the floor of the mouth. J Am Acad Dermatol, 2011, 6: 459460.
112.Kvien, T, Glennas, A, Melby, K, Granfors, K, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatology, 1994, 21: 115122.
113.Hill Gaston, JS, Lillicrap, MS. Arthritis associated with enteric infection. Clinical Rheumatology, 2003, 17: 219239.
114.Suhanga, J, Chakshu, A, Mohideen, K, et al. Cherubism combined with epilepsy, mental retardation and gingival fibromatosis. (Ramon syndrome): a case report. Head and Neck Pathol, 2010, 4: 12131.
115.Ramon, Y, Berman, W, Bubus, JJ. Gingival fibromatosis combined with Cherubism. Oral Surg, Oral Med, Oral Pathol, 1967, 24: 436448.
116.Hall, G. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol, 2001, 112: 851862.
117.Kasabach, HH, Merritt, KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child, 1940, 59: 1063.
118.el-Dessouky, M, Azmy, A, Raine, P, Young, D. Kasabach-Merritt syndrome. J Pediatr Surg, 1998, 23: 109111.
119.Enjolras, O, Mulliken, J, Wassef, M, Frieden, I, Rieu, P, Burrows, P, Salhi, A, Léauté-Labrèze, C, Kozakewich, H. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol, 2000, 42: 224235.
120.Stone, J. Neurological rarity: Parry-Romberg syndrome. Practical Neurology, 2006, 6: 185188.
121.Leao, M, da Silva, ML. Progressive hemifacial atrophy with agenesis of the head and the caudate nucleus. J Med Genetics, 1994, 31: 969971.
122.Muchnik, RS, Aston, SJ, Rees, TD. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmology, 1979, 88: 889897.
123.Lewkonia, RM, Lowry, RB, Opitz, JM. Progressive hemifacial atrophy (Parry-Romberg syndrome): report with review of genetics and nosology. Am J Med Genetics, 1983, 14: 385390.
124.Inigo, F, Jimenez-Murat, Y, Arroyo, O, Fernandez, M, Ysunza, A. Restoration of facial contour in Romberg’s disease and hemifacial microsomia. Experience with 118 cases. Microsurgery, 2000, 20: 167172.
125.Shirley, MD, Tang, H, Gallione, CJ, et al. Sturge-Weber syndrome and Port-wine stains caused by somatic mutations in GNAQ. New England J Med, 2013, 368: 19711979.
126.Sturge, WA. A case of partial epilepsy, apparently due to a lesion of one of the vasomotor centres of the brain. Transactions of the Clinical Society of London, 1879, 12: 162.
127.Greenwood, M, Meechan, JG. General medicine and surgery for dental practitioners Part 4: Neurological disorders. Br Dent, 2003, 195: 1925.
128.Weber, FP. Right-sided hemi-hypertrophy resulting from right-sided congenital spastic hemiplegia, with a morbid condition of the left side of the brain, revealed by radiograms. J Neurology and Psychopathology (London), 1922, 3: 134139.
129.Kubota, M, Usami, I, Yamakawa, M, Tomita, Y, Haruta, T. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. J Paediatrics and Child Health, 2008, 44: 359362.
130.Scardina, GA, Fucà, G, Carini, F, et al. Oral necrotizing microvasculitis in a patient affected by Kawasaki disease. Medicina Oral, Patologia Oral Y Cirugia Buc, 2007, 12: E560E564.
131.Do, JH, Baek, JG, Kim, HJ, et al. Kawasaki disease presenting as parotitis in a 3 month old infant. Korean Circulation Journal, 2009, 39: 502504.
132.Michie, C, Kinsler, V, Tulloh, R, Davidson, S. Recurrent skin peeling following Kawasaki disease. Archives of Disease in Childhood, 2000, 83: 353355.
133.Gardner, EJ, Richards, RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet, 1953, 5: 139147.
134.Knudsen, AL, Bisguard, ML, Bűlow, S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer, 2003, 2: 4355.
135.Miyoshi, Y, Nagase, H, Ando, H, et al. Somatic mutations of the APC gene in colorectal tumors. Mutation in the cluster region in the APC gene. Hum Mol Genet, 1992, 1: 229233.
136.Saurin, JC, Chayvialle, JA, Ponchon, T. Management of duodenal adenomas in familial adenomatous polyposis. Fam Cancer, 2008, 7: 173177.
137.Lourenco, SV, Boggio, P, Suquyama, K, et al. Severe and relapsing upper lip enlargement in a 10 year old boy. Acta Paediatr, 2010, 99: 1958.
138.Rogers RS, . Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin, 1996, 14: 371379.
139.Khouri, JM, Bohane, TD, Day, AS. Is orofacial granulomatosis in children a feature of Crohn’s disease. Acta Paediatr, 2005, 94: 501504.
140.Scully, C. Oral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment. Ed 3, Edinburgh: Churchill Livingstone, 2013, 298301.
141.Saalman, R, Sundell, S, Kullberg-Lindhc, C, et al. Long standing oral mucosal lesions in solid organ transplanted children – a novel clinical entity. Transplantation, 2010, 89: 606.
142.Williams, PM, Greenberg, MS. Management of cheilitis granulomatosa. Oral Surg, Oral Med, Oral Pathol, 1991, 72: 436439.
143.Kano, Y, Shiohara, T, Yagita, A, et al. Treatment of recalcitrant cheilitis granulomatosa with metronid. J. Am Acad Dermatol, 1992, 27: 629630 (a3.1).
144.Haverman, CW, Sloan, TB, Sloan, RT. Multiple endocrine neoplasia syndrome type III: review and case report. Spec Care Dentist, 1995, 15: 102106.
145.Pasquali, D, Matteo, FM, Renzullo, A, et al. Multiple endocrine neoplasia of the old and the new: mini review. G Ghir, 2012, 33: 370373.
146.Kahn, MA, Cote, J, Gagel, RE. RET proto-oncogene mutation analysis in multiple endocrine neoplasia syndrome type 2B. Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 82: 288294.
147.Raue, F, Frank-Raue, K. Multiple endocrine neoplasia type 2. Fam Cancer, 2010, 9: 449457.
148.Camacho, CP, Huff, AO, Lindsey, SC. Early diagnosis of multiple endocrine neoplasia syndrome type 2B. A challenge for physicians. Arq Bras Endocrine Metabol, 2008, 52: 13931398.
149.Fox, E, Widemann, BC, Ckuk, MK, et al. Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin Ca Res, 2013, 19: 42394248.
150.Mehta, A, Ricci, R, Widmer, U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. European J Clinic Invest, 2004, 34: 236242.
151.Gutierrez-Solana, LG. Advances in the treatment of lysosomal diseases in infancy. Rev Neural, 2006, 5:suppl 1: 137144.
152.Gorlin, RJ, Sedano, HO. Stomatologic aspects of cutaneous diseases: angiokeratoma corporis diffusum (Fabry syndrome). J Dermatol Surg Oncol, 1979, 5: 180181.
153.Altarescu, G, Berri, R, Eiges, R, et al. Prevention of lysosomal storage diseases and derivation of mutant stem cell liner by preimplantation genetic diagnosis. Mol Biol Int, 2012, doi 10.1155/2012/97342 Epub 2012, Dec 26.
154.Surjushe, A, Jindal, S, Sao, P, et al. Anderson-Fabrys disease with marfanoid features. Indian J Dermatol Venereol, 2008, 74: 389391.
155.Prasad, SS, Radharani, C, Sinna, S, et al. Hereditary gingival fibromatosis with distinctive facies. J Contemp Dent Pract, 2012, 1: 892896.
156.Shi, J, Lin, W, Li, X, et al. Hereditary gingival fibromatous a true generation case and pathologenic mechanism research on progress of the disease. J Periodontol, 2011, 82: 10891095.
157.Avelar, RL, deLana Campos, GJ, deCarvalho-Bezerra Falcao, PG, et al. Hereditary gingival fibromatosis: a report of four cases in the same family. Quintessence Int, 2010, 41: 99102.
158.Breen, GH, Adante, R, Black, CC. Early onset of hereditary gingival fibromatosis in a 28-month-old. Pediatr Dent, 2009, 31: 286288.
159.Martelli, H Jr, Santos, SM, Guimaraes, AL, et al. Idiopathic gingival fibromatosis: description of two cases. Minerva Stomatol, 2010, 59: 143148.
160.Byers, PH, Murray, ML, et al. Heritable collagen disorders. The paradigm of Ehlers Danlos syndrome. J Invest Dermatol, 2012, 15: E6E11. doi: 10.1038/skinbio.2012.3.
161.Eder, J, Laccone, F, Rohbach, M, et al. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV. Exp Dermatol, 2013, 22: 231234.
162.Mao, JR, Bristow, J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest, 2001, 107: 10631069.
163.Pinto, YM, Pals, G, Ziglstra, JG, et al. Ehlers-Danlos syndrome type IV. N Eng J Med, 2000, 343: 366368.
164.Yassin, OM, Rihani, FB. Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome. J Clin Pediatr Dent, 2006, 30: 337341.
165.Calva, D, Howe, JR. Hamartomatous polyposis syndromes. Surg Clin North Am, 2008, 88: 779817.
166.Brosens, LA, Van Hatley, WA, Jansen, M, et al. Gastrointestinal polyposis syndromes. Current Mol Med, 2007, 7: 2946.
167.Hinds, R, Philp, C, Hyer, W, et al. Complications of childhood Peutz-Jegher’s syndrome. Implications for pediatric screening. J Pediatr Gastroenteral Nutr, 2004, 39: 219220.
168.Mehenni, H, Blouin, JL, Radhakrishna, U, et al. Peutz-Jeghers syndrome: confirmation of a linkage to chromosome 19p13.3 and identification of a potential second locus on 19p13.4. Am J Hum Genet, 1997, 61: 13271334.
169.McCarity, TJ, Amos, C. Peutz-Jegher’s syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci, 2006, 63: 21352144.
170.Tovar, JA, Eizaquirre, I, Albert, A, et al. Peutz-Jegher’s syndroms in children: report of two cases and review of the literature. J Pediatr Surg, 1983, 18: 16.
171.Loeys, BL, Chen, J, Neptuine, ER. A syndroms of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 and TGFBR2. Nat Genet, 2005, 37: 275281.
172.Dean, JG. Marfan syndromes. Clinical diagnosis and management. European J Hum Genetics, 2007, 15: 724733.
173.deVries, BB, Pals, G, Odink, R, et al. Homozygosity for a FBN1 missence mutation clinical and molecular evidence for recessive Marfan syndrome. Eur J Hum Genet, 2007, 15: 930935.
174.Faivre, L, Gorlin, FJ, Wirtz, MK, et al. In frame fibrillin-1 gene deletion in autosomal dominant weill-marchesani syndrome. J Med Genet, 2003, 40: 3436.
175.Pyeitz, RE. The Marfan syndrome in childhood. Features, natural history and differential diagnosis. Prog Pediatric Cariol, 1996, 5: 151157.
176.Bolar, N, Van Laer, , Loeys, BL. Marfan syndrome: from gene to therapy. Curr Opin Pediatr, 2012, 24: 498504.
177.Cohen, MM Jr. Proteus syndrome: an update. Am J Med Genet C Seminar Med Genet, 2005, 137: 3852.
178.Hoey, SE, Eastwood, D, Monsell, , et al. Histopathological features of proteus syndrome. Clin Exp Dermatol, 2008, 33: 234238.
179.Happle, R. The manifold faces of proteus syndrome. Arch Dermatol, 2004, 140: 10011002.
180.Twede, JV, Turner, JT, Biesecker, LG, et al. Evolution of skin lesions in proteus syndrome. J Am Acad Dermatol, 2005, 52: 834838.
181.Cardoso, MT, deCarvalho, TB, Casulari, LA, et al. Proteus syndrome and somatic mosaigism of the chromosome 16. Panminerva Med, 2003, 45: 267271.
182.Lindhurst, MJ, Sapp, JC, Teer, JK, et al. A mosaic activating mutation in AKT1 associated with proteus syndrome. N Engl J Med, 2011, 365: 611619.
183.Bhupal, HK. Ramsay Hunt syndrome presenting in primary care. Practitioner, 2010, 254: 3335.
184.Kleinschmidt-DeMasters, BK, Gilden, DH. The expanding spectrum of herpes virus infections of the nervous system. Brainn Pthol, 2001, 11: 440451.
185.Sandoval, CC, Nunez, FA, Lizama, CM, et al. Ramsay Hunt syndrome in children: four cases and review. Rev Chilena Infectol, 2008, 25: 458464.
186.Ryer, EW, Lee, HY, Lee, SY, et al. Clinical manifestations and prognosis of patients with Ramsay Hunt syndrome. Am J Otolaryngol, 2011, 33: 313318.
187.Furuta, Y, Aizawa, H, Ohtani, F, et al. Varicella-Zoster virus reactivation on Ramsay Hunt syndrome. Ann Otol Rhinol Laryngol, 2004, 113: 700705.
188.Coffin, SE, Hodkinka, RL. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J Clin Microiol, 1995, 33: 27922795.
189.Naganawa, S, Nakashima, T. Cutting edge of inner ear MRI. Acta Otolaryngol Supp, 2009, 560: 1521.
190.Uscategui, T, Doree, C, Chamberlain, IJ, et al. Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Data Base System Review, Oct 8 2008, doi: 10.1002/14651858.
191.deRu, JA, VanBenthem, PP. Combination therapy is preferable for patients with Ramsay Hunt syndrome. Oto Neurotol, 2011, 32: 852855.
192.Albers–Schonberg, H. Roetgenbilder einer seltenen knochennerkrankung. Muuch Med Wochenschr, 1904, 51: 365.
193.Start, Z, Savarirayan, R. Osteopetrosis. Orphanet J Rare Dis, 2009, 4: 5.
194.Tritelbaum, SL. Bone resorption by osteoclasts. Science, 2000, 289: 15041508.
195.Wada, T, Nakashima, T, Oliveria-dos-Santos, , et al. The molecular scatfold Bag 2 is a critical component of RANK signaling and osteoclastogenesis. Nat Med, 2005, 11: 394399.
196.Cleiren, E, Benichou, O, VanHul, E, et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in CICN7 chloride channel gene. Hum Mol Genet, 2001, 10: 28612667.
197.Mazzolari, E, Forino, C, Razza, A, et al. A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol, 2009, 84: 473479.
198.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Chicago: Quintessence Publishing Company, 2012.
199.Symposium on osteopetrosis: proceedings and abstracts of the first interactive symposium on osteopetrosis: Biology and therapy. Oct 23–24, 2003, Bethesda Maryland. USA J Bone Miner Res, 2004, 19: 1356–1375.
200.Armstrong, DG, Newfield, JY, Gillespie, R. Orthopedic management of osteopetrosis: results of a survey and review of the literature. J Pediatr Orthop, 1999, 19: 122132.
201.Lata, PHJ, Sharma, R, Parmar, M. Massive osteolysis of hemimandible: a case report. J Maxillofac Oral Surg, 2009, 8: 381383.
202.Lee, S, Finn, L, Sze, RW. Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg, 2003, 129: 13401343.
203.Hu, P, Yuan, XG, Chan, XY, et al. Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature. J Zhejiang Univ Sci B, 2013, 14: 729735.
204.Ruggieri, P, Montalti, M, Angelini, A, et al. Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skeletal Radiol, 2011, 40: 13911397.
205.Dong, Q, Yafei, Z, Chuankong, S. Gorham-Stout syndrome affecting the left mandible: a case report. Exp Ther Med, 2013, 5: 162164.
206.Escande, C, Schouman, T, Francoise, G, et al. Histological features and management of a mandibular Gorham-Stout disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 106: e30e37.
207.Silva, S. Gorham-Stout disease affecting both hands: stabilization during bisphosphonate treatment. Hand (NY), 2011, 6: 8589.
208.Zheng, MW, Yang, M, Qiu, JX, et al. Gorham-Stout syndrome presenting in a 5-year-old girl with successful bisphosphonate therapeutic effect. Exp Ther Med, 2012, 4: 449451.
209.Nir, V, Guralnik, L, Livnat, G. Propranolol as a treatment option in Gorham-Stout syndrome. A case report. Pediatr Pulmonol, 2014, 49: 417419.
1.Baldwin, DJ, Thayalan, K, Amrita, J, et al. Glial choristoma of the tongue: report of a case and clinicopathological features. Int J of Pediatr Dent, 2009, 19: 219221.
2.Martinez-Peῆuela, A, Quer, S, Beloqui, R. Glial choristoma of the middle ear: report of 2 cases. Otology and Neurology, 2011, 32: e26e27.
3.Strome, SE, McClatchey, K, Kileny, PR, et al. Neonatal choristoma of the tongue containing glial tissue. Diagnostic and surgical considerations. Int J Pediatr Otorhino Laryngol, 1995, 33: 265273.
4.Sun, LS, Zhi-Peng, S, Xu-Chen, MA. Glial choristoma in the oral and maxillofacial region. A clinicopathologic study of 6 cases. Arch Pathol Lab Med, 2008, 132: 984998.
5.Fan, SQ, Ou, YM, Liang, QC. Glial choristoma of the tongue: report of a case and review of the literature. Pediatr Surg Int, 2008, 24: 515519.
6.Takamizawa, S, Inoue, T, Ono, Y, et al. A case report of glial choristoma of the tongue. J Pediatr Surg, 2006, 41: e13e15.
7.Fordyce, JA. A peculiar affection of the mucous membrane of the lips and oral cavity. J Cutan Dis, 1896, 14: 413419.
8.Lee, JH, Lee, JH, NA HK: Clinicopathologic manifestations of patients with Fordyce’s spots. Ann Dermatol, 2012, 24: 103106.
9.Oliver, JH. Fordyce granules on the prolabia and oral mucous membranes of a selected population. SADJ, 2006, 61: 7274.
10.DeFelice, C, Patrini, S, Chitano, G. et al. Fordyce granules and hereditary non-polyposis colorectal cancer syndrome. Gut, 2005, 41: 12791282.
11.Miller, AS, McCrea, MW. Sebaceous gland adenoma of the buccal mucosa. J Oral Surg, 1968, 26: 593595.
12.Miller, ML, Harford, RR, Yeager, JK. Fox Fordyce disease treated with topical clindamycin solution. Arch Dermatol, 1995, 131: 11121113.
13.Siggers, DC. Cleidocranial dysostosis. Dev Med Child Neurol, 1975, 4: 522524.
14.Shen, Z, Chio, C, Chun, Z, et al. Cleidocranial dysplasia: Report of 3 cases and literature review. Clinical Pediatrics, 2009, 2: 194198.
15.Bufalino, A, Paranaiba, LMR, Gouvêa, AF, et al. Cleidocranial dysplasia: oral features and genetic analysis of 11 patients. Oral Diseases, 2012, 18: 184190.
16.Ducy, P, Zhang, R, Geoffroy, V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997, 89: 747754.
17.Komori, T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res, 2010, 339: 189195.
18.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 231232.
19.Suda, N, Hattori, M, Kosaki, K, et al. Correlation between genotype and supernumerary tooth formation in cleidocranial dysplasia. Orthod Craniofac Res, 2010, 13: 197202.
20.Gorlin, RJ, Cohen, MN, Levin, LS. Syndromes of the Head and Neck. Ed 3, New York NY, Oxford University Press; 1990: 249253.
21.Jarvis, JL, Keats, TE. Cleidocranial dysostosis: a review of 40 new cases. Am J Roentgenol Radium Ther Nucl Med, 1974, 121: 516.
22.Perdigao, PF, Silva, ED, Sakurai, E, et al. Idiopathic bone cavity: a clinical, radiographic and histological study. Brit J Oral MG, 2003, 41: 407409.
23.Shigematsu, K, Fujita, W. Atypical simple bone cyst of the mandible. J Oral Maxillofac Surg, 1994, 23: 298299.
24.Manor, E, Kachko, L, Puterman, MB. Cystic lesions of the jaws: a clinicopathological study of 322 cases and review of the literature. Int J Med Sci, 2012, 9: 2026.
25.Patrikiou, A, Sepheriadouo-Mauropulou, G, Zambelis, G. Bilateral traumatic bone cysts of the mandible. Oral Surg, 1981, 51: 131133.
26.Zhu, L, Wang, X. Histological examination of the auricular cartilage and pseudocyst of the auricle. J Laryngol Otol, 1999, 106: 103104.
27.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 216217.
28.Velez, I, Siegel, MA, Mintz, SM et al. The relationship between idiopathic bone cavity and orthodontic tooth movement: analysis of 44 cases. Dentomaxillofac Radiol, 2010, 39: 162166.
29.Cortell-Ballester, I, Figueiredo, R, Berini-Aytes, L, et al. Traumatic bone cyst: a retrospective study of 21 cases. Med Oral Pathol Oral Cir Bucal 2009, 14: E239E243.
30.Kaffe, I, Littner, MM, Arensburg, B. The anterior buccal mandibular depression. Physical and radiologic features. Oral Surg Oral Med Oral Pathol, 1990, 69: 647654.
31.Apruzzese, D, Longoni, S. Stafne cyst in an anterior location. Oral Maxillofac Surg, 1999, 57: 333338.
32.Stafne, EC. Bone cavities situated near the angle of the mandible. J Am Dent Assoc, 1942, 29: 19691972.
33.Buchner, A, Carpenter, WM, Merrell, PW, et al. Anterior lingual salivary gland defect. Evaluation of twenty-four cases. Oral Surg Oral Med Oral Pathol, 1991, 71: 131136.
34.Shimizu, M, Osa, N, Okamura, K, et al. CT analysis of the Stafne’s bone defects of the mandible. Dentomaxillofac Radiol, 2006, 35: 95102.
35.Baughman, R. Testing your diagnostic skills. Case No. 2. Lingual mandibular salivary gland depression. Todays FDA, 2006, 18: 2023.
36.Sisman, Y, Miloglu, O, Sekerci, AE, et al. Radiographic evaluation of the prevalence of Stafne bone defect: a study from two centres in Turkey. Dentomaxillofacial Radiol, 2011, 35: 17.
37.Reye, RDK. A consideration of certain subdermal fibromatous tumors of infancy. J Pathol, 1956, 72: 149154.
38.Sotelo-Avilla, C, Bale, PM. Subdermal fibrous hamartomas of infancy: pathology of 40 cases and differential diagnosis. Pediatr Path, 1994, 14: 3952.
39.Paller, AS, Gonzalez-Grussi, F, Sherman, JO. Fibrous hamartomas of infancy: eight additional cases and a review of the literature. Arch Dermatol, 1989, 125: 8891.
40.Scott, DM, Pena, JR, Omura, E. Fibrous hamartomas of infancy. J Am Acad Dermatol, 1999, 41: 857858.
41.Westphal, SL, Bancila, E, Milgraum, SS. Fibrous hamartomas of infancy presenting as an inflamed epidermoid cyst. Pediatr Dermatol, 1990, 7: 157.
42.Boquot, JE, Gundlach, KKH. Odd tongues: the prevalence of common tongue lesions in 23,616 white Americans over 35 years of age. Quintessence Int, 1986, 17: 719730.
43.Ugar-Cankel, D, Denizci, S, Hocaoglu, J. Prevalence of tongue lesions among Turkish school children, Sandi Med, 2005, 26: 19621967.
44.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 99.
45.Mathew, AL, Pai, KM, Sholapurkar, AA, et al. The prevalence of oral mucosal lesions in patients visiting a dental school in Southern India. Indian J Dent Res, 2008, 19: 99103.
46.Koay, CL, Lim, JA, Siar, CH. The prevalence of tongue lesions in Malaysian dental out-patients from the Klang valley area. Oral Dis, 2011, 17: 210216.
47.Ohtani, J, Hoffman, WY, Vargevik, K. Team management and treatment outcomes for patients with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedies, 2012, 141: 574581.
48.Poswillo, D. The pathogenesis of first and second bronchial arch syndrome. Oral Surg, Oral Med, Oral Pathol, 1973, 35: 301328.
49.Kelberman, D, Tyson, DC, Chandler, AM, et al. Hemifacial microsomia: progress to understanding the genetic basis of a complex malformation syndrome. Hum Genet 2001, 109: 638645.
50.Pruzansky, S. Not all dwarfed mandibles are alike. Birth Defects, 1969, 4: 120129.
51.Cousley, RR A comparison of two classification systems for hemifacial microsomia. Br J Oral Maxillof Surg, 1993, 31: 7882.
52.Zanardi, G, Parente, EV, Esteves, LS. Orthodontic and surgical treatment of a patient with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedics, 2012, 141: 51305139.
53.Miranda, R, Barros, LM, Nogueira dos Santos, LA, et al. Clinical and imaging features in a patient with hemifacial hyperplasia. J Oral Sci, 2010, 52: 509512.
54.Bergman, JA. Primary hemifacial hypertrophy. Review and report of a case. Arch Otolaryngol, 1973, 97: 490494.
55.Yashimoto, H, Hano, H, Kobayashi, K, et al. Increased proliferative activity of osteoblasts in congenital hemifacial hypertrophy. Plast Reconstr Surg, 1998, 102: 16051610.
56.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Quintessence Publishing Company, 2012, 240
57.Islam, MN, Bhattacharyya, I, Ojha, J, et al. Comparison between true and partial hemifacial hypertrophy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 104: 501509.
58.Azevedo, RA, Veronica, FS, Sarmento, VA, et al. Hemifacial hyperplasia. A case report. Quintessence Int, 2005, 36: 483486.
59.Wisniewski, SA, Trzeciak, WH. A new mutation resulting in the truncation of the TRAF6-interacting domain of XEDAR: a possible novel cause of hypohidrotic ectodermal dysplasia. J Med Genet, 2012, 49: 499501.
60.Clarke, A. Hypohidrotic ectodermal dysplasia. J Med Genet, 1987, 24: 659663.
61.Subramaniam, P, Neeraja, G. Witkop’s tooth and nail syndrome: a multifaceted approach to dental management. J Indian Soc Pedod Prev Dent, 2008, 26: 2225.
62.Lamartine, J. Towards a new classification of ectodermal dysplasias. Cin Exp Dermatol, 2003, 28: 351355.
63.Priolo, M, Lagana, C. Ectodermal dysplasia a new clinical-genetic classification. J Med Genet, 2001, 38: 579585.
64.Guckes, AD, Brahim, JS, McCarthy, GR, et al. Using endosseous dental implants for patients with ectodermal dysplasia. JADA, 1991, 122: 5962.
65.Ekstrand, K, Thomsson, M. Ectodermal dysplasia with partial anodontia: prosthetic treatment with implant prosthesis. J Dent Child, 1988, 4: 282284.
66.Smith, RA, Vargervik, K, Kearns, G, et al. Placement of an endosseous implant in a growing child with ectodermal dysplasia. Oral Surg Oral Med Oral Pathol, 1993, 75: 669673.
67.Urzua, B, Ortega-Pento, , Morales-Bozo, et al. Defining a new candidate gene for amelogenesis imperfecta: from molecular genetics to biochemistry. Biochem Genet, 2011, 49: 104121.
68.Stephanopoulos, G, Garefalaki, E, Lyroudia, K. Genes and related proteins involved in amelogenesis imperfect. J Dent Res, 2005, 84: 11171126.
69.Weinmann, JP, Svobcda, JF, Woods, RW. Hereditary disturbances of enamel formation and calcification. J Am Dent Assoc, 1945, 32: 397418.
70.Chaudhary, M, Dixit, S, Singh, A. Amelogenesis imperfecta: reporting of a case and review of the literature. J Oral Maxillofac Pathol, 2009, 13: 7077.
71.Witkop, CJ Jr. Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification. J Oral Pathol Med, 1989, 17: 547543.
72.Schulze, C. Erbbedingte strukturanomalicin menschlicher zahne. Acta Genet Med Gemellol, 1957, 7: 231235.
73.Kinney, H, Pople, JA, Driessen, CH, et al. Intrafibrillar mineral may be absent in dentinogenesis imperfecta type II. J Dental Res, 2001, 1:80: 15551559.
74.Thofakura, SR, Mah, J, Srinivasan, R, et al. The non collagenous dentin matrix proteins are involved in dentinogenesis imperfecta type II. J Dent Res 2000, 79: 835839.
75.Bhandari, S, Pannu, K. Dentinogenesis imperfecta: a review and case report of a family over four generations. Indian J Dent Res, 2008, 19: 357361.
76.Shields, ED, Bixler, D, El-Kafrawy, AM. A proposed classification of heritable human dentin defect with a description of a new entity. Arch Oral Biol, 1973, 18: 543553.
77.Levin, LS, Leaf, SH, Jemini, RJ, et al. Dentinogenesis imperfecta in the Brandywine isolate hereditary opalescent dentin in an Ashkenazic Jewish family. Oral Surg Oral Med Oral Pathol, 1985, 59: 608615.
78.Von Marschall, Z, Mok, S, Phillips, MD. Rough endoplasmic reticulum trafficking errors by different classes of mutant dentin sialophosphorprotein (DSPP) causes dominant negative effects in both dentinogenesis imperfecta and dentin dysplasia by encapping normal DSPP. J Bone Miner Res, 2012, 27: 13091321.
79.Buday, K. Beiträge zar Lehre der osteogenesis imperfect, 1895.
80.Sillence, DO, Senn, A, Danks, DM. Genetic heterogenicity in osteogenesis imperfecta. J Med Genet, 1979, 16: 101116.
81.Rosen, A, Modig, M, Larson, O. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. Int J Oral Surg, 2011, 40: 866873.
82.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 232236.
83.Huber, MA. Osteogenesis imperfect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103: 314320.
84.Bergstrom, L. Osteogenesis imperfecta: otologic and maxillofacial aspects. Laryngoscope, 1977, 87: 142.
85.O’Connel, AC, Marini, JC. Evaluation of oral problems in an osteogenesis imperfect population. Oral SLurg Oral Med Oral Pathol Oral Radiol Endod, 1999, 87: 189196.
86.Kindelan, J, Tobin, M, Robert-Harry, RA. Orthodontic and orthognatic management of a patient with osteogenesis imperfect and dentinogenesis imperfect. A case report. J Orthod 2003, 30: 291296.
87.Marszalek, B, Wyojcicki, P, Kobus, K, et al. Clinical features, treatment and genetic background of Treacher Collins syndrome. J Appl Genet, 2002, 43: 223233.
88.Dixon, J, Edwards, SJ, Anderson, L. Identification of the complete coding sequence and genetic organization of the Treacher Collins syndrome gene. Genome Res, 1997, 7: 223234.
89.Rovin, S, Dachi, SF, Borenstein, DB, et al. Mandibulofacial dysostosis, a familial study of five generations. J Pediat, 1964, 65: 215221.
90.Jones, KL, Smith, DW, Harvey, MA, et al. Mandibulofacial dysostosis older paternal age and fresh gene mutation: data on additional disorders. J Pediat, 1975, 86: 8488.
91.LeMerrer, M, Cikuli, M, Ribier, J, et al. Acrofacial dysostosis. Am J Med Genet, 1989, 33: 318322.
92.Dixon, J, Trainor, MJ, Dixon, MJ. Treacher Collins syndrome. Orthodontics and Craniofacial Research, 2007, 10: 8895.
93.Horiuchi, K, Ariga, T, Fujioka, H, et al. Mutational analysis of the TCOF1 gene in 11 Japanese patients with Treacher Collins syndrome and mechanism of mutagenesis. J Med Genet, 2005, 134:363: 367.
94.Cohen, J, Ghezzi, F, Goncalves, L, et al. Prenatal sonographic diagnosis of Treacher Collins Syndrome: A case and review of the literature. Am J Perinatol, 1995, 12: 416419.
95.Cannon, AB. White nevus of the mucosa (naevus spongiosus albus mucosa) Arch Derm Syphiol, 1935, 31: 365373.
96.Hernandez-Martin, A, Fernandez-Lopez, E, deUnamuno, M. Diffuse whitening of the oral mucosa in a child. Pediatr Dermatol 1997, 14: 316320.
97.Naseem, S, Brady, R, McDonald, J. Diffuse white oral plaques. Clinical Infectious Diseases 2003, 36: 519520.
98.Jorgenson, RJ, Levin, LS. White sponge nevus. Arch Dermatol 1981, 117: 7376.
99.Allingham, RR, Seo, B, Rapersaud, E, et al. A duplication in chromosome 4q35 is associated with hereditary benign intraepithelial dyskeratosis. Am J Hum Genet 2001, 68: 491494.
100.Chao, SC, Tsai, Y-M, Yang, MH, et al. A novel mutation in the keratin 4 gene causing white sponge naevus. Br J Dermatol 2003, 184: 11251128.
101.Sadeghi, EM, Witkop, CJ. The presence of Candida albicans in hereditary benign intraepithelial dyskeratosis. An ultrastructural observation. Oral Surg Oral Med Oral Pathol 1979, 48: 342346.
102.Greer, RO Jr. Oral manifestations of smokeless tobacco use. Otolaryngologic Clinics of North America, 2010, 44: 3156.
103.Lim, J, Ng, S. Oral tetracycline rinse improves symptoms of white sponge nevus. J Am Acad Dermatol, 1992, 26: 10031005.
104.Elliott, M, Bayly, R, Cole, T, Temple, IK, Maher, ER. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clinical Genetics, 1994, 46, 168174.
105.Thorburn, MJ, Wright, ES, Miller, CG, Smith-Read, EHL. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. American J Diseases of Children, 1970, 119: 316321.
106.Pettenati, MJ, Haines, JL, Higgins, RR, Wappner, RS, Palmer, CG, Weaver, DD. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Human Genetics, 1986, 74: 143154.
107.DeBaun, MR, Niemitz, EL, McNeil, DE, Brandenburg, SA, Lee, MP, Feinberg, AP. Epigenetic alterations of H19 and L1T1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Human Genetics, 2002, 70: 604611.
108.Ullbro, C, Crossner, CG, Nederfors, T, Alfadley, A, Thestrup-Pedersen, K. Dermatological and oral findings in a cohort of 47 patients with Papillon-Lefevre syndrome. J Am Acad Dermatol, 2003, 48: 345351.
109.Cagli, NA, Hakki, SS, Darsun, R, et al. Clinical genetic, and biochemical findings in two siblings with Papillon-Lefévre syndrome. J Periodontal, 2005, 76: 23222329.
110.Wani, A, Devkar, N, Patole, M, Shouche, Y. Description of two new cathespin C gene mutations in patients with Papillon-Lefévre syndrome. J Peridontol, 2005, 76: 23222329.
111.Zadik, Y, Drucker, S, Pallmon, S. Migratory stomatitis (ectopic geographic tongue) on the floor of the mouth. J Am Acad Dermatol, 2011, 6: 459460.
112.Kvien, T, Glennas, A, Melby, K, Granfors, K, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatology, 1994, 21: 115122.
113.Hill Gaston, JS, Lillicrap, MS. Arthritis associated with enteric infection. Clinical Rheumatology, 2003, 17: 219239.
114.Suhanga, J, Chakshu, A, Mohideen, K, et al. Cherubism combined with epilepsy, mental retardation and gingival fibromatosis. (Ramon syndrome): a case report. Head and Neck Pathol, 2010, 4: 12131.
115.Ramon, Y, Berman, W, Bubus, JJ. Gingival fibromatosis combined with Cherubism. Oral Surg, Oral Med, Oral Pathol, 1967, 24: 436448.
116.Hall, G. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol, 2001, 112: 851862.
117.Kasabach, HH, Merritt, KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child, 1940, 59: 1063.
118.el-Dessouky, M, Azmy, A, Raine, P, Young, D. Kasabach-Merritt syndrome. J Pediatr Surg, 1998, 23: 109111.
119.Enjolras, O, Mulliken, J, Wassef, M, Frieden, I, Rieu, P, Burrows, P, Salhi, A, Léauté-Labrèze, C, Kozakewich, H. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol, 2000, 42: 224235.
120.Stone, J. Neurological rarity: Parry-Romberg syndrome. Practical Neurology, 2006, 6: 185188.
121.Leao, M, da Silva, ML. Progressive hemifacial atrophy with agenesis of the head and the caudate nucleus. J Med Genetics, 1994, 31: 969971.
122.Muchnik, RS, Aston, SJ, Rees, TD. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmology, 1979, 88: 889897.
123.Lewkonia, RM, Lowry, RB, Opitz, JM. Progressive hemifacial atrophy (Parry-Romberg syndrome): report with review of genetics and nosology. Am J Med Genetics, 1983, 14: 385390.
124.Inigo, F, Jimenez-Murat, Y, Arroyo, O, Fernandez, M, Ysunza, A. Restoration of facial contour in Romberg’s disease and hemifacial microsomia. Experience with 118 cases. Microsurgery, 2000, 20: 167172.
125.Shirley, MD, Tang, H, Gallione, CJ, et al. Sturge-Weber syndrome and Port-wine stains caused by somatic mutations in GNAQ. New England J Med, 2013, 368: 19711979.
126.Sturge, WA. A case of partial epilepsy, apparently due to a lesion of one of the vasomotor centres of the brain. Transactions of the Clinical Society of London, 1879, 12: 162.
127.Greenwood, M, Meechan, JG. General medicine and surgery for dental practitioners Part 4: Neurological disorders. Br Dent, 2003, 195: 1925.
128.Weber, FP. Right-sided hemi-hypertrophy resulting from right-sided congenital spastic hemiplegia, with a morbid condition of the left side of the brain, revealed by radiograms. J Neurology and Psychopathology (London), 1922, 3: 134139.
129.Kubota, M, Usami, I, Yamakawa, M, Tomita, Y, Haruta, T. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. J Paediatrics and Child Health, 2008, 44: 359362.
130.Scardina, GA, Fucà, G, Carini, F, et al. Oral necrotizing microvasculitis in a patient affected by Kawasaki disease. Medicina Oral, Patologia Oral Y Cirugia Buc, 2007, 12: E560E564.
131.Do, JH, Baek, JG, Kim, HJ, et al. Kawasaki disease presenting as parotitis in a 3 month old infant. Korean Circulation Journal, 2009, 39: 502504.
132.Michie, C, Kinsler, V, Tulloh, R, Davidson, S. Recurrent skin peeling following Kawasaki disease. Archives of Disease in Childhood, 2000, 83: 353355.
133.Gardner, EJ, Richards, RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet, 1953, 5: 139147.
134.Knudsen, AL, Bisguard, ML, Bűlow, S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer, 2003, 2: 4355.
135.Miyoshi, Y, Nagase, H, Ando, H, et al. Somatic mutations of the APC gene in colorectal tumors. Mutation in the cluster region in the APC gene. Hum Mol Genet, 1992, 1: 229233.
136.Saurin, JC, Chayvialle, JA, Ponchon, T. Management of duodenal adenomas in familial adenomatous polyposis. Fam Cancer, 2008, 7: 173177.
137.Lourenco, SV, Boggio, P, Suquyama, K, et al. Severe and relapsing upper lip enlargement in a 10 year old boy. Acta Paediatr, 2010, 99: 1958.
138.Rogers RS, . Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin, 1996, 14: 371379.
139.Khouri, JM, Bohane, TD, Day, AS. Is orofacial granulomatosis in children a feature of Crohn’s disease. Acta Paediatr, 2005, 94: 501504.
140.Scully, C. Oral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment. Ed 3, Edinburgh: Churchill Livingstone, 2013, 298301.
141.Saalman, R, Sundell, S, Kullberg-Lindhc, C, et al. Long standing oral mucosal lesions in solid organ transplanted children – a novel clinical entity. Transplantation, 2010, 89: 606.
142.Williams, PM, Greenberg, MS. Management of cheilitis granulomatosa. Oral Surg, Oral Med, Oral Pathol, 1991, 72: 436439.
143.Kano, Y, Shiohara, T, Yagita, A, et al. Treatment of recalcitrant cheilitis granulomatosa with metronid. J. Am Acad Dermatol, 1992, 27: 629630 (a3.1).
144.Haverman, CW, Sloan, TB, Sloan, RT. Multiple endocrine neoplasia syndrome type III: review and case report. Spec Care Dentist, 1995, 15: 102106.
145.Pasquali, D, Matteo, FM, Renzullo, A, et al. Multiple endocrine neoplasia of the old and the new: mini review. G Ghir, 2012, 33: 370373.
146.Kahn, MA, Cote, J, Gagel, RE. RET proto-oncogene mutation analysis in multiple endocrine neoplasia syndrome type 2B. Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 82: 288294.
147.Raue, F, Frank-Raue, K. Multiple endocrine neoplasia type 2. Fam Cancer, 2010, 9: 449457.
148.Camacho, CP, Huff, AO, Lindsey, SC. Early diagnosis of multiple endocrine neoplasia syndrome type 2B. A challenge for physicians. Arq Bras Endocrine Metabol, 2008, 52: 13931398.
149.Fox, E, Widemann, BC, Ckuk, MK, et al. Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin Ca Res, 2013, 19: 42394248.
150.Mehta, A, Ricci, R, Widmer, U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. European J Clinic Invest, 2004, 34: 236242.
151.Gutierrez-Solana, LG. Advances in the treatment of lysosomal diseases in infancy. Rev Neural, 2006, 5:suppl 1: 137144.
152.Gorlin, RJ, Sedano, HO. Stomatologic aspects of cutaneous diseases: angiokeratoma corporis diffusum (Fabry syndrome). J Dermatol Surg Oncol, 1979, 5: 180181.
153.Altarescu, G, Berri, R, Eiges, R, et al. Prevention of lysosomal storage diseases and derivation of mutant stem cell liner by preimplantation genetic diagnosis. Mol Biol Int, 2012, doi 10.1155/2012/97342 Epub 2012, Dec 26.
154.Surjushe, A, Jindal, S, Sao, P, et al. Anderson-Fabrys disease with marfanoid features. Indian J Dermatol Venereol, 2008, 74: 389391.
155.Prasad, SS, Radharani, C, Sinna, S, et al. Hereditary gingival fibromatosis with distinctive facies. J Contemp Dent Pract, 2012, 1: 892896.
156.Shi, J, Lin, W, Li, X, et al. Hereditary gingival fibromatous a true generation case and pathologenic mechanism research on progress of the disease. J Periodontol, 2011, 82: 10891095.
157.Avelar, RL, deLana Campos, GJ, deCarvalho-Bezerra Falcao, PG, et al. Hereditary gingival fibromatosis: a report of four cases in the same family. Quintessence Int, 2010, 41: 99102.
158.Breen, GH, Adante, R, Black, CC. Early onset of hereditary gingival fibromatosis in a 28-month-old. Pediatr Dent, 2009, 31: 286288.
159.Martelli, H Jr, Santos, SM, Guimaraes, AL, et al. Idiopathic gingival fibromatosis: description of two cases. Minerva Stomatol, 2010, 59: 143148.
160.Byers, PH, Murray, ML, et al. Heritable collagen disorders. The paradigm of Ehlers Danlos syndrome. J Invest Dermatol, 2012, 15: E6E11. doi: 10.1038/skinbio.2012.3.
161.Eder, J, Laccone, F, Rohbach, M, et al. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV. Exp Dermatol, 2013, 22: 231234.
162.Mao, JR, Bristow, J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest, 2001, 107: 10631069.
163.Pinto, YM, Pals, G, Ziglstra, JG, et al. Ehlers-Danlos syndrome type IV. N Eng J Med, 2000, 343: 366368.
164.Yassin, OM, Rihani, FB. Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome. J Clin Pediatr Dent, 2006, 30: 337341.
165.Calva, D, Howe, JR. Hamartomatous polyposis syndromes. Surg Clin North Am, 2008, 88: 779817.
166.Brosens, LA, Van Hatley, WA, Jansen, M, et al. Gastrointestinal polyposis syndromes. Current Mol Med, 2007, 7: 2946.
167.Hinds, R, Philp, C, Hyer, W, et al. Complications of childhood Peutz-Jegher’s syndrome. Implications for pediatric screening. J Pediatr Gastroenteral Nutr, 2004, 39: 219220.
168.Mehenni, H, Blouin, JL, Radhakrishna, U, et al. Peutz-Jeghers syndrome: confirmation of a linkage to chromosome 19p13.3 and identification of a potential second locus on 19p13.4. Am J Hum Genet, 1997, 61: 13271334.
169.McCarity, TJ, Amos, C. Peutz-Jegher’s syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci, 2006, 63: 21352144.
170.Tovar, JA, Eizaquirre, I, Albert, A, et al. Peutz-Jegher’s syndroms in children: report of two cases and review of the literature. J Pediatr Surg, 1983, 18: 16.
171.Loeys, BL, Chen, J, Neptuine, ER. A syndroms of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 and TGFBR2. Nat Genet, 2005, 37: 275281.
172.Dean, JG. Marfan syndromes. Clinical diagnosis and management. European J Hum Genetics, 2007, 15: 724733.
173.deVries, BB, Pals, G, Odink, R, et al. Homozygosity for a FBN1 missence mutation clinical and molecular evidence for recessive Marfan syndrome. Eur J Hum Genet, 2007, 15: 930935.
174.Faivre, L, Gorlin, FJ, Wirtz, MK, et al. In frame fibrillin-1 gene deletion in autosomal dominant weill-marchesani syndrome. J Med Genet, 2003, 40: 3436.
175.Pyeitz, RE. The Marfan syndrome in childhood. Features, natural history and differential diagnosis. Prog Pediatric Cariol, 1996, 5: 151157.
176.Bolar, N, Van Laer, , Loeys, BL. Marfan syndrome: from gene to therapy. Curr Opin Pediatr, 2012, 24: 498504.
177.Cohen, MM Jr. Proteus syndrome: an update. Am J Med Genet C Seminar Med Genet, 2005, 137: 3852.
178.Hoey, SE, Eastwood, D, Monsell, , et al. Histopathological features of proteus syndrome. Clin Exp Dermatol, 2008, 33: 234238.
179.Happle, R. The manifold faces of proteus syndrome. Arch Dermatol, 2004, 140: 10011002.
180.Twede, JV, Turner, JT, Biesecker, LG, et al. Evolution of skin lesions in proteus syndrome. J Am Acad Dermatol, 2005, 52: 834838.
181.Cardoso, MT, deCarvalho, TB, Casulari, LA, et al. Proteus syndrome and somatic mosaigism of the chromosome 16. Panminerva Med, 2003, 45: 267271.
182.Lindhurst, MJ, Sapp, JC, Teer, JK, et al. A mosaic activating mutation in AKT1 associated with proteus syndrome. N Engl J Med, 2011, 365: 611619.
183.Bhupal, HK. Ramsay Hunt syndrome presenting in primary care. Practitioner, 2010, 254: 3335.
184.Kleinschmidt-DeMasters, BK, Gilden, DH. The expanding spectrum of herpes virus infections of the nervous system. Brainn Pthol, 2001, 11: 440451.
185.Sandoval, CC, Nunez, FA, Lizama, CM, et al. Ramsay Hunt syndrome in children: four cases and review. Rev Chilena Infectol, 2008, 25: 458464.
186.Ryer, EW, Lee, HY, Lee, SY, et al. Clinical manifestations and prognosis of patients with Ramsay Hunt syndrome. Am J Otolaryngol, 2011, 33: 313318.
187.Furuta, Y, Aizawa, H, Ohtani, F, et al. Varicella-Zoster virus reactivation on Ramsay Hunt syndrome. Ann Otol Rhinol Laryngol, 2004, 113: 700705.
188.Coffin, SE, Hodkinka, RL. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J Clin Microiol, 1995, 33: 27922795.
189.Naganawa, S, Nakashima, T. Cutting edge of inner ear MRI. Acta Otolaryngol Supp, 2009, 560: 1521.
190.Uscategui, T, Doree, C, Chamberlain, IJ, et al. Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Data Base System Review, Oct 8 2008, doi: 10.1002/14651858.
191.deRu, JA, VanBenthem, PP. Combination therapy is preferable for patients with Ramsay Hunt syndrome. Oto Neurotol, 2011, 32: 852855.
192.Albers–Schonberg, H. Roetgenbilder einer seltenen knochennerkrankung. Muuch Med Wochenschr, 1904, 51: 365.
193.Start, Z, Savarirayan, R. Osteopetrosis. Orphanet J Rare Dis, 2009, 4: 5.
194.Tritelbaum, SL. Bone resorption by osteoclasts. Science, 2000, 289: 15041508.
195.Wada, T, Nakashima, T, Oliveria-dos-Santos, , et al. The molecular scatfold Bag 2 is a critical component of RANK signaling and osteoclastogenesis. Nat Med, 2005, 11: 394399.
196.Cleiren, E, Benichou, O, VanHul, E, et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in CICN7 chloride channel gene. Hum Mol Genet, 2001, 10: 28612667.
197.Mazzolari, E, Forino, C, Razza, A, et al. A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol, 2009, 84: 473479.
198.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Chicago: Quintessence Publishing Company, 2012.
199.Symposium on osteopetrosis: proceedings and abstracts of the first interactive symposium on osteopetrosis: Biology and therapy. Oct 23–24, 2003, Bethesda Maryland. USA J Bone Miner Res, 2004, 19: 1356–1375.
200.Armstrong, DG, Newfield, JY, Gillespie, R. Orthopedic management of osteopetrosis: results of a survey and review of the literature. J Pediatr Orthop, 1999, 19: 122132.
201.Lata, PHJ, Sharma, R, Parmar, M. Massive osteolysis of hemimandible: a case report. J Maxillofac Oral Surg, 2009, 8: 381383.
202.Lee, S, Finn, L, Sze, RW. Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg, 2003, 129: 13401343.
203.Hu, P, Yuan, XG, Chan, XY, et al. Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature. J Zhejiang Univ Sci B, 2013, 14: 729735.
204.Ruggieri, P, Montalti, M, Angelini, A, et al. Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skeletal Radiol, 2011, 40: 13911397.
205.Dong, Q, Yafei, Z, Chuankong, S. Gorham-Stout syndrome affecting the left mandible: a case report. Exp Ther Med, 2013, 5: 162164.
206.Escande, C, Schouman, T, Francoise, G, et al. Histological features and management of a mandibular Gorham-Stout disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 106: e30e37.
207.Silva, S. Gorham-Stout disease affecting both hands: stabilization during bisphosphonate treatment. Hand (NY), 2011, 6: 8589.
208.Zheng, MW, Yang, M, Qiu, JX, et al. Gorham-Stout syndrome presenting in a 5-year-old girl with successful bisphosphonate therapeutic effect. Exp Ther Med, 2012, 4: 449451.
209.Nir, V, Guralnik, L, Livnat, G. Propranolol as a treatment option in Gorham-Stout syndrome. A case report. Pediatr Pulmonol, 2014, 49: 417419.
1.Baldwin, DJ, Thayalan, K, Amrita, J, et al. Glial choristoma of the tongue: report of a case and clinicopathological features. Int J of Pediatr Dent, 2009, 19: 219221.
2.Martinez-Peῆuela, A, Quer, S, Beloqui, R. Glial choristoma of the middle ear: report of 2 cases. Otology and Neurology, 2011, 32: e26e27.
3.Strome, SE, McClatchey, K, Kileny, PR, et al. Neonatal choristoma of the tongue containing glial tissue. Diagnostic and surgical considerations. Int J Pediatr Otorhino Laryngol, 1995, 33: 265273.
4.Sun, LS, Zhi-Peng, S, Xu-Chen, MA. Glial choristoma in the oral and maxillofacial region. A clinicopathologic study of 6 cases. Arch Pathol Lab Med, 2008, 132: 984998.
5.Fan, SQ, Ou, YM, Liang, QC. Glial choristoma of the tongue: report of a case and review of the literature. Pediatr Surg Int, 2008, 24: 515519.
6.Takamizawa, S, Inoue, T, Ono, Y, et al. A case report of glial choristoma of the tongue. J Pediatr Surg, 2006, 41: e13e15.
7.Fordyce, JA. A peculiar affection of the mucous membrane of the lips and oral cavity. J Cutan Dis, 1896, 14: 413419.
8.Lee, JH, Lee, JH, NA HK: Clinicopathologic manifestations of patients with Fordyce’s spots. Ann Dermatol, 2012, 24: 103106.
9.Oliver, JH. Fordyce granules on the prolabia and oral mucous membranes of a selected population. SADJ, 2006, 61: 7274.
10.DeFelice, C, Patrini, S, Chitano, G. et al. Fordyce granules and hereditary non-polyposis colorectal cancer syndrome. Gut, 2005, 41: 12791282.
11.Miller, AS, McCrea, MW. Sebaceous gland adenoma of the buccal mucosa. J Oral Surg, 1968, 26: 593595.
12.Miller, ML, Harford, RR, Yeager, JK. Fox Fordyce disease treated with topical clindamycin solution. Arch Dermatol, 1995, 131: 11121113.
13.Siggers, DC. Cleidocranial dysostosis. Dev Med Child Neurol, 1975, 4: 522524.
14.Shen, Z, Chio, C, Chun, Z, et al. Cleidocranial dysplasia: Report of 3 cases and literature review. Clinical Pediatrics, 2009, 2: 194198.
15.Bufalino, A, Paranaiba, LMR, Gouvêa, AF, et al. Cleidocranial dysplasia: oral features and genetic analysis of 11 patients. Oral Diseases, 2012, 18: 184190.
16.Ducy, P, Zhang, R, Geoffroy, V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 1997, 89: 747754.
17.Komori, T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res, 2010, 339: 189195.
18.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 231232.
19.Suda, N, Hattori, M, Kosaki, K, et al. Correlation between genotype and supernumerary tooth formation in cleidocranial dysplasia. Orthod Craniofac Res, 2010, 13: 197202.
20.Gorlin, RJ, Cohen, MN, Levin, LS. Syndromes of the Head and Neck. Ed 3, New York NY, Oxford University Press; 1990: 249253.
21.Jarvis, JL, Keats, TE. Cleidocranial dysostosis: a review of 40 new cases. Am J Roentgenol Radium Ther Nucl Med, 1974, 121: 516.
22.Perdigao, PF, Silva, ED, Sakurai, E, et al. Idiopathic bone cavity: a clinical, radiographic and histological study. Brit J Oral MG, 2003, 41: 407409.
23.Shigematsu, K, Fujita, W. Atypical simple bone cyst of the mandible. J Oral Maxillofac Surg, 1994, 23: 298299.
24.Manor, E, Kachko, L, Puterman, MB. Cystic lesions of the jaws: a clinicopathological study of 322 cases and review of the literature. Int J Med Sci, 2012, 9: 2026.
25.Patrikiou, A, Sepheriadouo-Mauropulou, G, Zambelis, G. Bilateral traumatic bone cysts of the mandible. Oral Surg, 1981, 51: 131133.
26.Zhu, L, Wang, X. Histological examination of the auricular cartilage and pseudocyst of the auricle. J Laryngol Otol, 1999, 106: 103104.
27.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 216217.
28.Velez, I, Siegel, MA, Mintz, SM et al. The relationship between idiopathic bone cavity and orthodontic tooth movement: analysis of 44 cases. Dentomaxillofac Radiol, 2010, 39: 162166.
29.Cortell-Ballester, I, Figueiredo, R, Berini-Aytes, L, et al. Traumatic bone cyst: a retrospective study of 21 cases. Med Oral Pathol Oral Cir Bucal 2009, 14: E239E243.
30.Kaffe, I, Littner, MM, Arensburg, B. The anterior buccal mandibular depression. Physical and radiologic features. Oral Surg Oral Med Oral Pathol, 1990, 69: 647654.
31.Apruzzese, D, Longoni, S. Stafne cyst in an anterior location. Oral Maxillofac Surg, 1999, 57: 333338.
32.Stafne, EC. Bone cavities situated near the angle of the mandible. J Am Dent Assoc, 1942, 29: 19691972.
33.Buchner, A, Carpenter, WM, Merrell, PW, et al. Anterior lingual salivary gland defect. Evaluation of twenty-four cases. Oral Surg Oral Med Oral Pathol, 1991, 71: 131136.
34.Shimizu, M, Osa, N, Okamura, K, et al. CT analysis of the Stafne’s bone defects of the mandible. Dentomaxillofac Radiol, 2006, 35: 95102.
35.Baughman, R. Testing your diagnostic skills. Case No. 2. Lingual mandibular salivary gland depression. Todays FDA, 2006, 18: 2023.
36.Sisman, Y, Miloglu, O, Sekerci, AE, et al. Radiographic evaluation of the prevalence of Stafne bone defect: a study from two centres in Turkey. Dentomaxillofacial Radiol, 2011, 35: 17.
37.Reye, RDK. A consideration of certain subdermal fibromatous tumors of infancy. J Pathol, 1956, 72: 149154.
38.Sotelo-Avilla, C, Bale, PM. Subdermal fibrous hamartomas of infancy: pathology of 40 cases and differential diagnosis. Pediatr Path, 1994, 14: 3952.
39.Paller, AS, Gonzalez-Grussi, F, Sherman, JO. Fibrous hamartomas of infancy: eight additional cases and a review of the literature. Arch Dermatol, 1989, 125: 8891.
40.Scott, DM, Pena, JR, Omura, E. Fibrous hamartomas of infancy. J Am Acad Dermatol, 1999, 41: 857858.
41.Westphal, SL, Bancila, E, Milgraum, SS. Fibrous hamartomas of infancy presenting as an inflamed epidermoid cyst. Pediatr Dermatol, 1990, 7: 157.
42.Boquot, JE, Gundlach, KKH. Odd tongues: the prevalence of common tongue lesions in 23,616 white Americans over 35 years of age. Quintessence Int, 1986, 17: 719730.
43.Ugar-Cankel, D, Denizci, S, Hocaoglu, J. Prevalence of tongue lesions among Turkish school children, Sandi Med, 2005, 26: 19621967.
44.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 99.
45.Mathew, AL, Pai, KM, Sholapurkar, AA, et al. The prevalence of oral mucosal lesions in patients visiting a dental school in Southern India. Indian J Dent Res, 2008, 19: 99103.
46.Koay, CL, Lim, JA, Siar, CH. The prevalence of tongue lesions in Malaysian dental out-patients from the Klang valley area. Oral Dis, 2011, 17: 210216.
47.Ohtani, J, Hoffman, WY, Vargevik, K. Team management and treatment outcomes for patients with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedies, 2012, 141: 574581.
48.Poswillo, D. The pathogenesis of first and second bronchial arch syndrome. Oral Surg, Oral Med, Oral Pathol, 1973, 35: 301328.
49.Kelberman, D, Tyson, DC, Chandler, AM, et al. Hemifacial microsomia: progress to understanding the genetic basis of a complex malformation syndrome. Hum Genet 2001, 109: 638645.
50.Pruzansky, S. Not all dwarfed mandibles are alike. Birth Defects, 1969, 4: 120129.
51.Cousley, RR A comparison of two classification systems for hemifacial microsomia. Br J Oral Maxillof Surg, 1993, 31: 7882.
52.Zanardi, G, Parente, EV, Esteves, LS. Orthodontic and surgical treatment of a patient with hemifacial microsomia. Am J Orthodontics and Dentofacial Orthopedics, 2012, 141: 51305139.
53.Miranda, R, Barros, LM, Nogueira dos Santos, LA, et al. Clinical and imaging features in a patient with hemifacial hyperplasia. J Oral Sci, 2010, 52: 509512.
54.Bergman, JA. Primary hemifacial hypertrophy. Review and report of a case. Arch Otolaryngol, 1973, 97: 490494.
55.Yashimoto, H, Hano, H, Kobayashi, K, et al. Increased proliferative activity of osteoblasts in congenital hemifacial hypertrophy. Plast Reconstr Surg, 1998, 102: 16051610.
56.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Quintessence Publishing Company, 2012, 240
57.Islam, MN, Bhattacharyya, I, Ojha, J, et al. Comparison between true and partial hemifacial hypertrophy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 104: 501509.
58.Azevedo, RA, Veronica, FS, Sarmento, VA, et al. Hemifacial hyperplasia. A case report. Quintessence Int, 2005, 36: 483486.
59.Wisniewski, SA, Trzeciak, WH. A new mutation resulting in the truncation of the TRAF6-interacting domain of XEDAR: a possible novel cause of hypohidrotic ectodermal dysplasia. J Med Genet, 2012, 49: 499501.
60.Clarke, A. Hypohidrotic ectodermal dysplasia. J Med Genet, 1987, 24: 659663.
61.Subramaniam, P, Neeraja, G. Witkop’s tooth and nail syndrome: a multifaceted approach to dental management. J Indian Soc Pedod Prev Dent, 2008, 26: 2225.
62.Lamartine, J. Towards a new classification of ectodermal dysplasias. Cin Exp Dermatol, 2003, 28: 351355.
63.Priolo, M, Lagana, C. Ectodermal dysplasia a new clinical-genetic classification. J Med Genet, 2001, 38: 579585.
64.Guckes, AD, Brahim, JS, McCarthy, GR, et al. Using endosseous dental implants for patients with ectodermal dysplasia. JADA, 1991, 122: 5962.
65.Ekstrand, K, Thomsson, M. Ectodermal dysplasia with partial anodontia: prosthetic treatment with implant prosthesis. J Dent Child, 1988, 4: 282284.
66.Smith, RA, Vargervik, K, Kearns, G, et al. Placement of an endosseous implant in a growing child with ectodermal dysplasia. Oral Surg Oral Med Oral Pathol, 1993, 75: 669673.
67.Urzua, B, Ortega-Pento, , Morales-Bozo, et al. Defining a new candidate gene for amelogenesis imperfecta: from molecular genetics to biochemistry. Biochem Genet, 2011, 49: 104121.
68.Stephanopoulos, G, Garefalaki, E, Lyroudia, K. Genes and related proteins involved in amelogenesis imperfect. J Dent Res, 2005, 84: 11171126.
69.Weinmann, JP, Svobcda, JF, Woods, RW. Hereditary disturbances of enamel formation and calcification. J Am Dent Assoc, 1945, 32: 397418.
70.Chaudhary, M, Dixit, S, Singh, A. Amelogenesis imperfecta: reporting of a case and review of the literature. J Oral Maxillofac Pathol, 2009, 13: 7077.
71.Witkop, CJ Jr. Amelogenesis imperfecta, dentinogenesis imperfecta and dentin dysplasia revisited: problems in classification. J Oral Pathol Med, 1989, 17: 547543.
72.Schulze, C. Erbbedingte strukturanomalicin menschlicher zahne. Acta Genet Med Gemellol, 1957, 7: 231235.
73.Kinney, H, Pople, JA, Driessen, CH, et al. Intrafibrillar mineral may be absent in dentinogenesis imperfecta type II. J Dental Res, 2001, 1:80: 15551559.
74.Thofakura, SR, Mah, J, Srinivasan, R, et al. The non collagenous dentin matrix proteins are involved in dentinogenesis imperfecta type II. J Dent Res 2000, 79: 835839.
75.Bhandari, S, Pannu, K. Dentinogenesis imperfecta: a review and case report of a family over four generations. Indian J Dent Res, 2008, 19: 357361.
76.Shields, ED, Bixler, D, El-Kafrawy, AM. A proposed classification of heritable human dentin defect with a description of a new entity. Arch Oral Biol, 1973, 18: 543553.
77.Levin, LS, Leaf, SH, Jemini, RJ, et al. Dentinogenesis imperfecta in the Brandywine isolate hereditary opalescent dentin in an Ashkenazic Jewish family. Oral Surg Oral Med Oral Pathol, 1985, 59: 608615.
78.Von Marschall, Z, Mok, S, Phillips, MD. Rough endoplasmic reticulum trafficking errors by different classes of mutant dentin sialophosphorprotein (DSPP) causes dominant negative effects in both dentinogenesis imperfecta and dentin dysplasia by encapping normal DSPP. J Bone Miner Res, 2012, 27: 13091321.
79.Buday, K. Beiträge zar Lehre der osteogenesis imperfect, 1895.
80.Sillence, DO, Senn, A, Danks, DM. Genetic heterogenicity in osteogenesis imperfecta. J Med Genet, 1979, 16: 101116.
81.Rosen, A, Modig, M, Larson, O. Orthognathic bimaxillary surgery in two patients with osteogenesis imperfecta and a review of the literature. Int J Oral Surg, 2011, 40: 866873.
82.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Ed 2, Chicago: Quintessence Publishing Company, 2012, 232236.
83.Huber, MA. Osteogenesis imperfect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2007, 103: 314320.
84.Bergstrom, L. Osteogenesis imperfecta: otologic and maxillofacial aspects. Laryngoscope, 1977, 87: 142.
85.O’Connel, AC, Marini, JC. Evaluation of oral problems in an osteogenesis imperfect population. Oral SLurg Oral Med Oral Pathol Oral Radiol Endod, 1999, 87: 189196.
86.Kindelan, J, Tobin, M, Robert-Harry, RA. Orthodontic and orthognatic management of a patient with osteogenesis imperfect and dentinogenesis imperfect. A case report. J Orthod 2003, 30: 291296.
87.Marszalek, B, Wyojcicki, P, Kobus, K, et al. Clinical features, treatment and genetic background of Treacher Collins syndrome. J Appl Genet, 2002, 43: 223233.
88.Dixon, J, Edwards, SJ, Anderson, L. Identification of the complete coding sequence and genetic organization of the Treacher Collins syndrome gene. Genome Res, 1997, 7: 223234.
89.Rovin, S, Dachi, SF, Borenstein, DB, et al. Mandibulofacial dysostosis, a familial study of five generations. J Pediat, 1964, 65: 215221.
90.Jones, KL, Smith, DW, Harvey, MA, et al. Mandibulofacial dysostosis older paternal age and fresh gene mutation: data on additional disorders. J Pediat, 1975, 86: 8488.
91.LeMerrer, M, Cikuli, M, Ribier, J, et al. Acrofacial dysostosis. Am J Med Genet, 1989, 33: 318322.
92.Dixon, J, Trainor, MJ, Dixon, MJ. Treacher Collins syndrome. Orthodontics and Craniofacial Research, 2007, 10: 8895.
93.Horiuchi, K, Ariga, T, Fujioka, H, et al. Mutational analysis of the TCOF1 gene in 11 Japanese patients with Treacher Collins syndrome and mechanism of mutagenesis. J Med Genet, 2005, 134:363: 367.
94.Cohen, J, Ghezzi, F, Goncalves, L, et al. Prenatal sonographic diagnosis of Treacher Collins Syndrome: A case and review of the literature. Am J Perinatol, 1995, 12: 416419.
95.Cannon, AB. White nevus of the mucosa (naevus spongiosus albus mucosa) Arch Derm Syphiol, 1935, 31: 365373.
96.Hernandez-Martin, A, Fernandez-Lopez, E, deUnamuno, M. Diffuse whitening of the oral mucosa in a child. Pediatr Dermatol 1997, 14: 316320.
97.Naseem, S, Brady, R, McDonald, J. Diffuse white oral plaques. Clinical Infectious Diseases 2003, 36: 519520.
98.Jorgenson, RJ, Levin, LS. White sponge nevus. Arch Dermatol 1981, 117: 7376.
99.Allingham, RR, Seo, B, Rapersaud, E, et al. A duplication in chromosome 4q35 is associated with hereditary benign intraepithelial dyskeratosis. Am J Hum Genet 2001, 68: 491494.
100.Chao, SC, Tsai, Y-M, Yang, MH, et al. A novel mutation in the keratin 4 gene causing white sponge naevus. Br J Dermatol 2003, 184: 11251128.
101.Sadeghi, EM, Witkop, CJ. The presence of Candida albicans in hereditary benign intraepithelial dyskeratosis. An ultrastructural observation. Oral Surg Oral Med Oral Pathol 1979, 48: 342346.
102.Greer, RO Jr. Oral manifestations of smokeless tobacco use. Otolaryngologic Clinics of North America, 2010, 44: 3156.
103.Lim, J, Ng, S. Oral tetracycline rinse improves symptoms of white sponge nevus. J Am Acad Dermatol, 1992, 26: 10031005.
104.Elliott, M, Bayly, R, Cole, T, Temple, IK, Maher, ER. Clinical features and natural history of Beckwith-Wiedemann syndrome: presentation of 74 new cases. Clinical Genetics, 1994, 46, 168174.
105.Thorburn, MJ, Wright, ES, Miller, CG, Smith-Read, EHL. Exomphalos-macroglossia-gigantism syndrome in Jamaican infants. American J Diseases of Children, 1970, 119: 316321.
106.Pettenati, MJ, Haines, JL, Higgins, RR, Wappner, RS, Palmer, CG, Weaver, DD. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Human Genetics, 1986, 74: 143154.
107.DeBaun, MR, Niemitz, EL, McNeil, DE, Brandenburg, SA, Lee, MP, Feinberg, AP. Epigenetic alterations of H19 and L1T1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Human Genetics, 2002, 70: 604611.
108.Ullbro, C, Crossner, CG, Nederfors, T, Alfadley, A, Thestrup-Pedersen, K. Dermatological and oral findings in a cohort of 47 patients with Papillon-Lefevre syndrome. J Am Acad Dermatol, 2003, 48: 345351.
109.Cagli, NA, Hakki, SS, Darsun, R, et al. Clinical genetic, and biochemical findings in two siblings with Papillon-Lefévre syndrome. J Periodontal, 2005, 76: 23222329.
110.Wani, A, Devkar, N, Patole, M, Shouche, Y. Description of two new cathespin C gene mutations in patients with Papillon-Lefévre syndrome. J Peridontol, 2005, 76: 23222329.
111.Zadik, Y, Drucker, S, Pallmon, S. Migratory stomatitis (ectopic geographic tongue) on the floor of the mouth. J Am Acad Dermatol, 2011, 6: 459460.
112.Kvien, T, Glennas, A, Melby, K, Granfors, K, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatology, 1994, 21: 115122.
113.Hill Gaston, JS, Lillicrap, MS. Arthritis associated with enteric infection. Clinical Rheumatology, 2003, 17: 219239.
114.Suhanga, J, Chakshu, A, Mohideen, K, et al. Cherubism combined with epilepsy, mental retardation and gingival fibromatosis. (Ramon syndrome): a case report. Head and Neck Pathol, 2010, 4: 12131.
115.Ramon, Y, Berman, W, Bubus, JJ. Gingival fibromatosis combined with Cherubism. Oral Surg, Oral Med, Oral Pathol, 1967, 24: 436448.
116.Hall, G. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol, 2001, 112: 851862.
117.Kasabach, HH, Merritt, KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child, 1940, 59: 1063.
118.el-Dessouky, M, Azmy, A, Raine, P, Young, D. Kasabach-Merritt syndrome. J Pediatr Surg, 1998, 23: 109111.
119.Enjolras, O, Mulliken, J, Wassef, M, Frieden, I, Rieu, P, Burrows, P, Salhi, A, Léauté-Labrèze, C, Kozakewich, H. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol, 2000, 42: 224235.
120.Stone, J. Neurological rarity: Parry-Romberg syndrome. Practical Neurology, 2006, 6: 185188.
121.Leao, M, da Silva, ML. Progressive hemifacial atrophy with agenesis of the head and the caudate nucleus. J Med Genetics, 1994, 31: 969971.
122.Muchnik, RS, Aston, SJ, Rees, TD. Ocular manifestations and treatment of hemifacial atrophy. Am J Ophthalmology, 1979, 88: 889897.
123.Lewkonia, RM, Lowry, RB, Opitz, JM. Progressive hemifacial atrophy (Parry-Romberg syndrome): report with review of genetics and nosology. Am J Med Genetics, 1983, 14: 385390.
124.Inigo, F, Jimenez-Murat, Y, Arroyo, O, Fernandez, M, Ysunza, A. Restoration of facial contour in Romberg’s disease and hemifacial microsomia. Experience with 118 cases. Microsurgery, 2000, 20: 167172.
125.Shirley, MD, Tang, H, Gallione, CJ, et al. Sturge-Weber syndrome and Port-wine stains caused by somatic mutations in GNAQ. New England J Med, 2013, 368: 19711979.
126.Sturge, WA. A case of partial epilepsy, apparently due to a lesion of one of the vasomotor centres of the brain. Transactions of the Clinical Society of London, 1879, 12: 162.
127.Greenwood, M, Meechan, JG. General medicine and surgery for dental practitioners Part 4: Neurological disorders. Br Dent, 2003, 195: 1925.
128.Weber, FP. Right-sided hemi-hypertrophy resulting from right-sided congenital spastic hemiplegia, with a morbid condition of the left side of the brain, revealed by radiograms. J Neurology and Psychopathology (London), 1922, 3: 134139.
129.Kubota, M, Usami, I, Yamakawa, M, Tomita, Y, Haruta, T. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations. J Paediatrics and Child Health, 2008, 44: 359362.
130.Scardina, GA, Fucà, G, Carini, F, et al. Oral necrotizing microvasculitis in a patient affected by Kawasaki disease. Medicina Oral, Patologia Oral Y Cirugia Buc, 2007, 12: E560E564.
131.Do, JH, Baek, JG, Kim, HJ, et al. Kawasaki disease presenting as parotitis in a 3 month old infant. Korean Circulation Journal, 2009, 39: 502504.
132.Michie, C, Kinsler, V, Tulloh, R, Davidson, S. Recurrent skin peeling following Kawasaki disease. Archives of Disease in Childhood, 2000, 83: 353355.
133.Gardner, EJ, Richards, RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet, 1953, 5: 139147.
134.Knudsen, AL, Bisguard, ML, Bűlow, S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer, 2003, 2: 4355.
135.Miyoshi, Y, Nagase, H, Ando, H, et al. Somatic mutations of the APC gene in colorectal tumors. Mutation in the cluster region in the APC gene. Hum Mol Genet, 1992, 1: 229233.
136.Saurin, JC, Chayvialle, JA, Ponchon, T. Management of duodenal adenomas in familial adenomatous polyposis. Fam Cancer, 2008, 7: 173177.
137.Lourenco, SV, Boggio, P, Suquyama, K, et al. Severe and relapsing upper lip enlargement in a 10 year old boy. Acta Paediatr, 2010, 99: 1958.
138.Rogers RS, . Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin, 1996, 14: 371379.
139.Khouri, JM, Bohane, TD, Day, AS. Is orofacial granulomatosis in children a feature of Crohn’s disease. Acta Paediatr, 2005, 94: 501504.
140.Scully, C. Oral and Maxillofacial Medicine: The Basis of Diagnosis and Treatment. Ed 3, Edinburgh: Churchill Livingstone, 2013, 298301.
141.Saalman, R, Sundell, S, Kullberg-Lindhc, C, et al. Long standing oral mucosal lesions in solid organ transplanted children – a novel clinical entity. Transplantation, 2010, 89: 606.
142.Williams, PM, Greenberg, MS. Management of cheilitis granulomatosa. Oral Surg, Oral Med, Oral Pathol, 1991, 72: 436439.
143.Kano, Y, Shiohara, T, Yagita, A, et al. Treatment of recalcitrant cheilitis granulomatosa with metronid. J. Am Acad Dermatol, 1992, 27: 629630 (a3.1).
144.Haverman, CW, Sloan, TB, Sloan, RT. Multiple endocrine neoplasia syndrome type III: review and case report. Spec Care Dentist, 1995, 15: 102106.
145.Pasquali, D, Matteo, FM, Renzullo, A, et al. Multiple endocrine neoplasia of the old and the new: mini review. G Ghir, 2012, 33: 370373.
146.Kahn, MA, Cote, J, Gagel, RE. RET proto-oncogene mutation analysis in multiple endocrine neoplasia syndrome type 2B. Case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 82: 288294.
147.Raue, F, Frank-Raue, K. Multiple endocrine neoplasia type 2. Fam Cancer, 2010, 9: 449457.
148.Camacho, CP, Huff, AO, Lindsey, SC. Early diagnosis of multiple endocrine neoplasia syndrome type 2B. A challenge for physicians. Arq Bras Endocrine Metabol, 2008, 52: 13931398.
149.Fox, E, Widemann, BC, Ckuk, MK, et al. Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma. Clin Ca Res, 2013, 19: 42394248.
150.Mehta, A, Ricci, R, Widmer, U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry outcome survey. European J Clinic Invest, 2004, 34: 236242.
151.Gutierrez-Solana, LG. Advances in the treatment of lysosomal diseases in infancy. Rev Neural, 2006, 5:suppl 1: 137144.
152.Gorlin, RJ, Sedano, HO. Stomatologic aspects of cutaneous diseases: angiokeratoma corporis diffusum (Fabry syndrome). J Dermatol Surg Oncol, 1979, 5: 180181.
153.Altarescu, G, Berri, R, Eiges, R, et al. Prevention of lysosomal storage diseases and derivation of mutant stem cell liner by preimplantation genetic diagnosis. Mol Biol Int, 2012, doi 10.1155/2012/97342 Epub 2012, Dec 26.
154.Surjushe, A, Jindal, S, Sao, P, et al. Anderson-Fabrys disease with marfanoid features. Indian J Dermatol Venereol, 2008, 74: 389391.
155.Prasad, SS, Radharani, C, Sinna, S, et al. Hereditary gingival fibromatosis with distinctive facies. J Contemp Dent Pract, 2012, 1: 892896.
156.Shi, J, Lin, W, Li, X, et al. Hereditary gingival fibromatous a true generation case and pathologenic mechanism research on progress of the disease. J Periodontol, 2011, 82: 10891095.
157.Avelar, RL, deLana Campos, GJ, deCarvalho-Bezerra Falcao, PG, et al. Hereditary gingival fibromatosis: a report of four cases in the same family. Quintessence Int, 2010, 41: 99102.
158.Breen, GH, Adante, R, Black, CC. Early onset of hereditary gingival fibromatosis in a 28-month-old. Pediatr Dent, 2009, 31: 286288.
159.Martelli, H Jr, Santos, SM, Guimaraes, AL, et al. Idiopathic gingival fibromatosis: description of two cases. Minerva Stomatol, 2010, 59: 143148.
160.Byers, PH, Murray, ML, et al. Heritable collagen disorders. The paradigm of Ehlers Danlos syndrome. J Invest Dermatol, 2012, 15: E6E11. doi: 10.1038/skinbio.2012.3.
161.Eder, J, Laccone, F, Rohbach, M, et al. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV. Exp Dermatol, 2013, 22: 231234.
162.Mao, JR, Bristow, J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest, 2001, 107: 10631069.
163.Pinto, YM, Pals, G, Ziglstra, JG, et al. Ehlers-Danlos syndrome type IV. N Eng J Med, 2000, 343: 366368.
164.Yassin, OM, Rihani, FB. Multiple developmental dental anomalies and hypermobility type Ehlers-Danlos syndrome. J Clin Pediatr Dent, 2006, 30: 337341.
165.Calva, D, Howe, JR. Hamartomatous polyposis syndromes. Surg Clin North Am, 2008, 88: 779817.
166.Brosens, LA, Van Hatley, WA, Jansen, M, et al. Gastrointestinal polyposis syndromes. Current Mol Med, 2007, 7: 2946.
167.Hinds, R, Philp, C, Hyer, W, et al. Complications of childhood Peutz-Jegher’s syndrome. Implications for pediatric screening. J Pediatr Gastroenteral Nutr, 2004, 39: 219220.
168.Mehenni, H, Blouin, JL, Radhakrishna, U, et al. Peutz-Jeghers syndrome: confirmation of a linkage to chromosome 19p13.3 and identification of a potential second locus on 19p13.4. Am J Hum Genet, 1997, 61: 13271334.
169.McCarity, TJ, Amos, C. Peutz-Jegher’s syndrome: clinicopathology and molecular alterations. Cell Mol Life Sci, 2006, 63: 21352144.
170.Tovar, JA, Eizaquirre, I, Albert, A, et al. Peutz-Jegher’s syndroms in children: report of two cases and review of the literature. J Pediatr Surg, 1983, 18: 16.
171.Loeys, BL, Chen, J, Neptuine, ER. A syndroms of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 and TGFBR2. Nat Genet, 2005, 37: 275281.
172.Dean, JG. Marfan syndromes. Clinical diagnosis and management. European J Hum Genetics, 2007, 15: 724733.
173.deVries, BB, Pals, G, Odink, R, et al. Homozygosity for a FBN1 missence mutation clinical and molecular evidence for recessive Marfan syndrome. Eur J Hum Genet, 2007, 15: 930935.
174.Faivre, L, Gorlin, FJ, Wirtz, MK, et al. In frame fibrillin-1 gene deletion in autosomal dominant weill-marchesani syndrome. J Med Genet, 2003, 40: 3436.
175.Pyeitz, RE. The Marfan syndrome in childhood. Features, natural history and differential diagnosis. Prog Pediatric Cariol, 1996, 5: 151157.
176.Bolar, N, Van Laer, , Loeys, BL. Marfan syndrome: from gene to therapy. Curr Opin Pediatr, 2012, 24: 498504.
177.Cohen, MM Jr. Proteus syndrome: an update. Am J Med Genet C Seminar Med Genet, 2005, 137: 3852.
178.Hoey, SE, Eastwood, D, Monsell, , et al. Histopathological features of proteus syndrome. Clin Exp Dermatol, 2008, 33: 234238.
179.Happle, R. The manifold faces of proteus syndrome. Arch Dermatol, 2004, 140: 10011002.
180.Twede, JV, Turner, JT, Biesecker, LG, et al. Evolution of skin lesions in proteus syndrome. J Am Acad Dermatol, 2005, 52: 834838.
181.Cardoso, MT, deCarvalho, TB, Casulari, LA, et al. Proteus syndrome and somatic mosaigism of the chromosome 16. Panminerva Med, 2003, 45: 267271.
182.Lindhurst, MJ, Sapp, JC, Teer, JK, et al. A mosaic activating mutation in AKT1 associated with proteus syndrome. N Engl J Med, 2011, 365: 611619.
183.Bhupal, HK. Ramsay Hunt syndrome presenting in primary care. Practitioner, 2010, 254: 3335.
184.Kleinschmidt-DeMasters, BK, Gilden, DH. The expanding spectrum of herpes virus infections of the nervous system. Brainn Pthol, 2001, 11: 440451.
185.Sandoval, CC, Nunez, FA, Lizama, CM, et al. Ramsay Hunt syndrome in children: four cases and review. Rev Chilena Infectol, 2008, 25: 458464.
186.Ryer, EW, Lee, HY, Lee, SY, et al. Clinical manifestations and prognosis of patients with Ramsay Hunt syndrome. Am J Otolaryngol, 2011, 33: 313318.
187.Furuta, Y, Aizawa, H, Ohtani, F, et al. Varicella-Zoster virus reactivation on Ramsay Hunt syndrome. Ann Otol Rhinol Laryngol, 2004, 113: 700705.
188.Coffin, SE, Hodkinka, RL. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J Clin Microiol, 1995, 33: 27922795.
189.Naganawa, S, Nakashima, T. Cutting edge of inner ear MRI. Acta Otolaryngol Supp, 2009, 560: 1521.
190.Uscategui, T, Doree, C, Chamberlain, IJ, et al. Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. Cochrane Data Base System Review, Oct 8 2008, doi: 10.1002/14651858.
191.deRu, JA, VanBenthem, PP. Combination therapy is preferable for patients with Ramsay Hunt syndrome. Oto Neurotol, 2011, 32: 852855.
192.Albers–Schonberg, H. Roetgenbilder einer seltenen knochennerkrankung. Muuch Med Wochenschr, 1904, 51: 365.
193.Start, Z, Savarirayan, R. Osteopetrosis. Orphanet J Rare Dis, 2009, 4: 5.
194.Tritelbaum, SL. Bone resorption by osteoclasts. Science, 2000, 289: 15041508.
195.Wada, T, Nakashima, T, Oliveria-dos-Santos, , et al. The molecular scatfold Bag 2 is a critical component of RANK signaling and osteoclastogenesis. Nat Med, 2005, 11: 394399.
196.Cleiren, E, Benichou, O, VanHul, E, et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in CICN7 chloride channel gene. Hum Mol Genet, 2001, 10: 28612667.
197.Mazzolari, E, Forino, C, Razza, A, et al. A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol, 2009, 84: 473479.
198.Marx, RE, Stern, D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. Chicago: Quintessence Publishing Company, 2012.
199.Symposium on osteopetrosis: proceedings and abstracts of the first interactive symposium on osteopetrosis: Biology and therapy. Oct 23–24, 2003, Bethesda Maryland. USA J Bone Miner Res, 2004, 19: 1356–1375.
200.Armstrong, DG, Newfield, JY, Gillespie, R. Orthopedic management of osteopetrosis: results of a survey and review of the literature. J Pediatr Orthop, 1999, 19: 122132.
201.Lata, PHJ, Sharma, R, Parmar, M. Massive osteolysis of hemimandible: a case report. J Maxillofac Oral Surg, 2009, 8: 381383.
202.Lee, S, Finn, L, Sze, RW. Gorham Stout syndrome (disappearing bone disease): two additional case reports and a review of the literature. Arch Otolaryngol Head Neck Surg, 2003, 129: 13401343.
203.Hu, P, Yuan, XG, Chan, XY, et al. Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature. J Zhejiang Univ Sci B, 2013, 14: 729735.
204.Ruggieri, P, Montalti, M, Angelini, A, et al. Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skeletal Radiol, 2011, 40: 13911397.
205.Dong, Q, Yafei, Z, Chuankong, S. Gorham-Stout syndrome affecting the left mandible: a case report. Exp Ther Med, 2013, 5: 162164.
206.Escande, C, Schouman, T, Francoise, G, et al. Histological features and management of a mandibular Gorham-Stout disease: a case report and review of maxillofacial cases in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 106: e30e37.
207.Silva, S. Gorham-Stout disease affecting both hands: stabilization during bisphosphonate treatment. Hand (NY), 2011, 6: 8589.
208.Zheng, MW, Yang, M, Qiu, JX, et al. Gorham-Stout syndrome presenting in a 5-year-old girl with successful bisphosphonate therapeutic effect. Exp Ther Med, 2012, 4: 449451.
209.Nir, V, Guralnik, L, Livnat, G. Propranolol as a treatment option in Gorham-Stout syndrome. A case report. Pediatr Pulmonol, 2014, 49: 417419.